Led by National Institute for Health and Care Research (NIHR) Senior Investigator Professor Kevin Munro, the research team surveyed a representative sample of over 2,000 adults in the UK about their willingness to test their own hearing at home and use pre-programmed or self-fit hearing aids.

Almost 9 in every 10 adults surveyed said they would be willing to test their own hearing at home if recommended by the NHS.

The majority also said they would be willing to try a hearing aid that was sent to them by the NHS either ready programmed or which required them to programme it for themselves.  

The current NHS pathway involves GPs making a referral for a face-to-face appointment with an NHS audiologist in a hospital or high street setting. The uptake of hearing care is low and slow and current waiting times are very long.

However, policymakers are encouraging self-monitoring of health, and for health services to make greater use of digital technology as well as provide care closer to home.

The findings are a positive indication that such an approach would be welcomed by at least a proportion of adults.   

A variety of apps and online tests are available for people to assess their hearing at home using their smartphone or tablet, and there are hearing aids that are available without the need to involve a hearing professional. However, these vary in quality, and not all have been properly evaluated.

The findings are published in the International Journal of Audiology.

The study was funded by an NIHR Senior Investigator award to Prof Munro and was supported by the NIHR 野狼社区 Biomedical Research Centre (BRC).

Prof Kevin Munro said: 鈥淚f evaluated and shown to be successful for adults who prefer this option, DIY ear care has the potential to increase patient choice and shift care closer to home. It will also free up audiologists鈥� time to spend with adults who most need their help.鈥�

However, Prof Munro cautions that more work is needed before the findings are rolled out into practice: 鈥淲e have yet to evaluate whether this willingness will translate into reality or whether audiologists would be comfortable with this approach. We would also need to determine what support the NHS should provide to adults who opt to use these new pathways.鈥�

Professor Gabrielle Saunders from The University of 野狼社区 and Hearing Health Co-Theme Lead at the NIHR 野狼社区 BRC, a co-author of the study said: 鈥淭he main benefits reported in the survey include convenience, immediacy (not needing to wait for an appointment) and savings for the NHS. However, respondents raised genuine concerns that will need to be addressed including uncertainty about trusting the test results and feeling confident that they did the testing properly in the absence of face-to-face support.鈥� 

Claire Benton, President of the British Academy of Audiology, said:   鈥淭he profession is keen to foster a culture of continuous improvement, and these findings are very interesting. It is clear there is a need to provide a variety of solutions to resolve the current pressures. If the benefit to patients is not inferior to current practice, this provides additional options that are potentially sustainable solution for the NHS.鈥�

However, Benton went on to note: 鈥淭hese low-touch digital solutions will not be suitable for everyone. Also, we need to be reassured that we will not miss anyone with ear disease that requires medical attention.鈥�

Professor De wet Swanepoel, editor-in-chief of the International Journal of Audiology said: "Traditional models of hearing care can no longer meet the near-universal demand among older adults. This study highlights that adults themselves recognise the need for more accessible, self-directed models of care 鈥� a shift that is both necessary and transformative for healthy ageing.鈥�

According to RNID, 1 in 3 adults in the UK have some sort of hearing disorder, which is a total of over 18 million people. The prevalence increases significantly with age, with over half of people aged 55 or more having hearing loss. The number is projected to rise, with estimates suggesting 14.2 million adults will have hearing loss by 2035.

• The paper: DIY audiology at home: adults are interested in conducting self-administered hearing tests and trying fit-at-home hearing aids is published . The DOI of the paper is: 10.1080/14992027.2025.2576030.T

The study in older animals  showed that the placentas of male but not female offspring had increased cell damage from a biological state called oxidative stress. 

Oxidative stress occurs when harmful molecules called free radicals build up faster than the body can clear them. 

It is associated with a range of pregnancy complications including fetal growth restriction and preeclampsia, both of which increase the risk of stillbirth. 

The study demonstrated reduced weight in both female and male fetuses in older mice, but the placental alterations were sex-specific. 

The scientists are conducting further studies in mice to confirm these findings  and also carrying out a parallel study to see if similar sex differentiated mechanisms exist in human placentas from mothers of advanced maternal age (AMA), defined as age 35 and over. 

The study, published in the journal Reproduction and funded by Tommy鈥檚 and the Medical Research Council, also discovered placental mitochondria -  the biological batteries that power cells-  were working at a reduced rate in the placentas of both male and female pups but that there were more of them. 

Mitochondria are a major source of free radicals. Reducing their rate of activity at the same time as increasing their numbers is a way they adapt to prevent further oxidative stress while maintaining the supply of energy needed for cells to work properly.

This could mean that the adaptation in placentas from females was more successful than in placentas from males because oxidative stress was not increased in placentas from females of older mice. 

Although scientists know AMA increases the risk of placental dysfunction leading to  fetal growth restriction and stillbirth, little is known about the mechanisms that cause it.

Lead author Dr Michelles Desforges from the University of 野狼社区  said: 鈥淪ome impacts of advanced maternal age appear common to both sexes but this data suggests some may be sex specific.

鈥淓vidence that sex differentiated placental dysfunction occurs in a range of risk groups -  including diabetes or obesity- has been around for some time.

鈥淭his, however, is amongst the few to delve into the sex differentiated processes which increase the risks of adverse pregnancy outcome in animals of advanced maternal age.

鈥淚n 1980, only around 6% of pregnant women in the UK were aged 35 and over. However this figure has now risen to 25%. This represents a massive societal shift and it is important that we understand the reasons why these pregnancies are more vulnerable to fetal growth restriction and stillbirth.

鈥淏耻迟 it is important to stress, however, that though advanced maternal age comes with  increased risks for some women, the  majority of mums aged 35 and over have normal pregnancies and healthy babies.鈥�

Principle investigator Dr Mark Dilworth added: 鈥淪tudies in mice are particularly helpful as they allow us to compare male and female offspring in the same pregnancy. In addition, these studies provide an important basis for future studies intent on developing therapeutic strategies for preventing fetal growth restriction and stillbirth.鈥�

• Sex-specific alterations in placental mitochondria, oxidative damage and apoptosis in mice of advanced maternal age鈥� is available .DOI: 

Researchers at the 野狼社区 Breast Centre, based at The University of 野狼社区, found that blocking the effects of the hormone progesterone, using ulipristal acetate, a drug already used on the NHS, may reduce the risk of breast cancer developing in women before the menopause, with a strong family history of the disease.

Progesterone is a hormone that can drive breast cancer development. It promotes the growth of a type of breast cell, that has the potential to turn into breast cancer. It can also influence the environment inside the breast, making it easier for these healthy cells to transform into cancer cells.

Blocking these effects of progesterone could be a new way to stop breast cancer before it starts.

The study, published today in the journal Nature, found that taking ulipristal acetate helped block the growth of breast cells that can turn into cancer, called luminal progenitors. These cells are the starting point for triple negative breast cancer, a more aggressive form of the disease that is more common in younger women and black women. Previous research has shown that the risk of triple negative breast cancer coming back or spreading in the first few years after diagnosis, is higher than in other types of breast cancer.

Between 2016 and 2019, 24 women aged 34-44 with a family history of breast cancer took ulipristal acetate for a 12-week period. During the trial, they underwent breast biopsies, blood tests, and detailed Magnetic Resonance Imaging (MRI) scans before and after treatment.

The researchers were measuring changes in breast tissue to understand if the drug might have a protective effect against breast cancer development.

MRI scans showed that the breast tissue became less dense with treatment, which is important because higher breast density is known to increase risk of breast cancer. The team found that the treatment worked best in women who had high breast density before treatment started.

Researchers also observed dramatic changes in breast tissue.  They found that treatment significantly reduced the number and function of certain collagen proteins that normally help support breast tissue.  Overall, the breast tissue became less stiff, making the environment less favourable for cancers to develop and grow.

One protein in particular 鈥� collagen 6 鈥� showed the most noticeable decrease after treatment. Based on their findings, researchers now think that it may directly influence the behaviour of luminal progenitor cells, that can give rise to breast cancer. 

All these changes suggest that the drug alters breast tissue in a way that makes it harder for cancer cells to develop and grow, therefore reducing the risk of breast cancer.

Clinical lead author, Dr Sacha Howell, Clinical senior lecturer at The University of 野狼社区, Director of 野狼社区 Breast Centre and Consultant Oncologist at The Christie said: 鈥淲e are profoundly grateful to the women who volunteered for this study. Our research, with them, provides evidence that progesterone plays a critical role in breast cancer development in high-risk individuals. By targeting its action, ulipristal acetate and other anti-progestins show promise as preventive treatments for women at increased risk.

鈥淲hat makes this study particularly exciting is the combination of clinical imaging and biological analysis, which gives us a powerful tool to understand how prevention therapies work at both the tissue and molecular levels. These results lay important groundwork for larger trials to confirm the potential of anti-progestins in reducing breast cancer risk鈥�.

Laboratory lead author, Dr Bruno Sim玫es, research fellow at The University of 野狼社区 and Principal Investigator at the 野狼社区 Breast Centre said: 鈥淥ur team was intrigued by how anti-progestins reshaped the breast tissue environment at the molecular level, reducing the number of tumour-initiating cells. We observed clear reductions in collagen levels and organisation, giving us direct insight into how targeting progesterone signalling can create conditions that make it harder for cancers to develop.鈥�

鈥淥ur goal is to understand the biology underlying breast cancer risk factors so we can develop better strategies to reduce the number of women affected by the disease. This study is particularly exciting because it suggests that women with increased breast density, a well-established risk factor, may benefit most from preventive treatment with an anti-progestin drug.鈥�

Co-lead author, Rob Clarke, professor of breast biology at the University of 野狼社区, Principal Investigator and former Director of the 野狼社区 Breast Centre said: 鈥淭he biological research behind the clinical study was a great example of team science, a major collaboration between investigators in 野狼社区, Cambridge and Toronto coming

together to understand the breast tissue and cellular changes underlying this preventive treatment. The findings reveal biomarkers that could be used to gauge response to therapy and whether it will be effective in preventing breast cancer.鈥�

Dr Simon Vincent, chief scientific officer at Breast Cancer Now, which funded the research, said: 鈥淲e desperately need better risk-reducing treatments for women at high risk of breast cancer, that also protect their quality of life. And we need to explore all avenues, including existing drugs with the scope to be repurposed, to achieve this.

鈥淐urrently, these women have only two options to reduce their risk - surgery or long-term hormone therapy, both of which have a profound impact on their physical and emotional wellbeing.

鈥淭his research into ulipristal acetate is an important step forward, and aligns with our key strategic goal to accelerate the discovery of preventative treatments.  We now need larger, longer-term studies, so we can fully understand the potential of this drug to stop breast cancer developing.鈥�

Grace Burton, 27, from Bromley London, underwent a preventative double mastectomy last year after finding out she was at high risk of breast cancer due to an inherited BRCA1 gene change at the age of 21.

Grace says: 鈥淏reast cancer has had a huge impact on my family - both my mum and my aunt were diagnosed, and knowing I was at high risk was always in the back of my mind. Having later gone through preventative surgery myself, I know how heavy and difficult those decisions can feel. That鈥檚 why this new research into preventative medication is so exciting, it offers hope for other women who might one day have less invasive options to protect their health.

鈥淔or those of us with a strong family history, the possibility of preventing breast cancer before it starts is incredible. It gives me hope that future generations may not have to make the same tough choices and can grow up with more options and less fear around breast cancer.鈥�

Several of the authors were supported by the National Institute for Health and Care Research (NIHR) 野狼社区 Biomedical Research Centre (BRC).

The research is published in Nature and is  available

DOI: 10.1038/s41586-025-09684-7   

Professor Rosalie David and Dr Roger Forshaw show in their book, published by Liverpool University Press  in paperback this month, how Western medical practice owes a debt of thanks to the Ancient Egyptians. 

Though previous works have highlighted the diseases that affected the Egyptians thousands of years ago, this is the first to be written from the perspective of the ancient equivalent of doctors, patients and nurses. 

According to the authors, the system can be seen as a precursor to the healthcare of today: the equivalent of consultants 鈥� with different specialisms-    and GPs treated patients either at home in the community or in something resembling hospitals. 

Nurses cared for patients and midwives -  usually women - were highly respected and according to one account were paid more than the doctors. 

Student medics , who were often male relatives of existing doctors,  were trained in temples. Discoveries of mummies also showed that patients who lived with long term debilitating  illness were presumably cared  for by nurses and support workers during their lives. 

If they needed the ancient equivalent of hospital treatment, patients stayed in small cells attached to a temple -  such as at the temple of Denderah in upper Egypt-  where they would be looked after by priest-doctors. 

The care  was paid for either in kind by the patients themselves-  who donated food or other items to the temple - or some assistance was provided by the State for particular groups -  almost like the state healthcare of today. 

The system was so successful that if you made it past the first 5 years of life, your  life expectancy was similar to that of many British people  in Victorian times-  between 30 and  40. 

What the authors call 鈥榬ational鈥� treatments were given for problems that could be seen, such  as bandaging for broken bones. There was even a form of palliative care for the terminally ill. 

Balanites oil-   which is extracted from parts of the Desert Date tree  - was often successfully prescribed by community doctors to  treat bilharzia or Schistosomiasis-  a devastating disease caused by parasitic worms. The treatment was still used in modern medicine up to  50 years ago. 

However the less commonly used 鈥榠rrational鈥� treatments, where it wasn鈥檛 possible  to see the origin of the disease such as mental illness- involved the use of spells and magic.

Much of the information about ancient Egyptian healthcare was derived by the researchers from medical papyri discovered  in different locations across Egypt.

The papyri give details on disease, diagnosis, and treatments, including herbal remedies, surgery, and magical incantations.

Only 12 of these medical papyri are known today from over 3,000 years of history: others undoubtedly existed and may in future be discovered during excavations or identified in modern library collections of papyri.

The economically successful New Kingdom (1550 BCE 鈥� 1069 BCE)  and the Greco Roman Period  from around the beginning of the common era, were probably the high point for healthcare in ancient Egypt said Professor David, though it probably existed from at least around 3000 BC she added.

The book, called Medicine and Healing Practices in Ancient Egypt, shows how European, Arabic and ancient Greek medicine all  have a direct lineage to healthcare  practice that was common 3000 years ago.

Professor David said: 鈥淲e鈥檙e delighted our book is available in paperback, which means the public, medics and Egyptology buffs will not just enjoy it, but learn about the important contribution of ancient Egyptian healthcare to our systems of today.鈥�

鈥淭hough punishments could be quite vicious if you transgressed the legal code, the perception that ancient Egypt was a violent and unpleasant  place is completely wrong.

鈥淭hey believed in an afterlife where there was no aging, or illness-  but to get there you had to be on the straight and narrow.鈥�

鈥淭hat might at least partially explain why, for most of the time, it was a well-organised society which cared for its people in a way which far exceeded anything else in the ancient world.鈥�

Images:

• The remains of a schistosome, the causative parasite for the disease Bilharzia, discovered in an Egyptian mummy. Parasite DNA was for the first time identified in this sample
• Sanatorium at Temple of Hathor at Denderah
• Cover of book: Medicine and Healing Practices in Ancient Egypt
• Statue of Sekhmet, lioness-headed goddess of medicine
• Temple of Hatshepsut at Deir el-Bahri where patients received medical treatment

The study by health economists at The University of 野狼社区 and funded by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration Greater 野狼社区 (ARC-GM), is published today in the journal Quality of Life Research.

The authors  also say that people from different ethnic groups with health conditions rated their quality of life differently, even when they reported similar prevalence of actual illness.

The findings bring us closer to confirming  what researchers have explored but where further empirical evidence was still needed .

Based on the data from General Practice Patient Survey in England 鈥� including 2.3 million White respondents, 160 thousand Asian, 70 thousand Black, 20 thousand of Mixed or Multiple background, and 60 thousand from Other ethnic groups 鈥� the findings have potential implications on the equitable design of health services and the way health outcomes are measured.

Though the survey data used in the study relies on self-reported long term health conditions to capture illness, the measure is thought to be more objective than other studies to date for England. It鈥檚 also the largest study to yet tackle differences in self-rating.

Lead author Dr Juan Marcelo Virdis from the University of 野狼社区 said: 鈥淥ur study found that certain black and Asian ethnic groups could be more likely to downplay different aspects of how health affects their lives.

鈥淭his is important because differences between perceived and actual health can affect how you seek healthcare health care and could, for example, delay a clinical consultation.

鈥淏耻迟 understanding these differences is crucial for designing equitable health services and improving outcomes across diverse populations.鈥�

The researchers based their analysis on EQ-5D-5L, a standardized measurement tool developed by a group of European researchers called EuroQol Group (EQ) to measure health-related quality of life.

5D refers to five self-reported dimensions of health it assesses: mobility, self-care, usual activities, pain/discomfort, anxiety/depression.

And  the 5L refers to five levels of self-reported severity for each dimension: no problems, slight problems, moderate problems, severe problems, extreme problems/unable.

They analysed five distinct ethnic groups: White ethnic, mixed background, Asian, Black and Other who reported which  of  15 long term health conditions they had.

In some cases - such as Mobility for the Black and Other ethnic groups or Self-care for the Asian-  the tendency was to choose extreme categories. The study also explored differences within these broader ethnic groups, suggesting that heterogeneity may exist within them as well.

Though the reason why some ethnic groups report differently remain  unclear, some researchers speculate that we answer subjective questions on health by saying what is normal for us, influenced by our background and expectations.

Dr Virdis added: 鈥淥ur research provides a scenario for further studies using objectively measured health conditions, such as biological risk factors, or objective measures of physical health such as grip strength. In addition, we were not able to investigate the mechanisms at play, so this could be a focus for future qualitative research.鈥�

The paper Differences in rating of health related quality of life on the EQ-5D-5L between ethnic groups is published . DOI: 10.1007/s11136-025-04082-y 

Aurore Hochard, Director at MEC, brought Startup Weekend to the University of 野狼社区 in 2024, shortly after joining the team. Following the huge success of the very first Startup Weekend initiative, it has since become a flagship event at the Masood Entrepreneurship Centre, championing entrepreneurship among students across the university. 

This year鈥檚 event, organised by Joana Carneiro (Enterprise Innovation Administrator at MEC) and Izzy Paton (Operations Administrator at MEC), brought together industry experts, speakers, and mentors to spark and celebrate entrepreneurship, showcasing both emerging and established talent. 

Across the weekend, participants pitched ideas, formed teams, and developed startup concepts with guidance from experienced mentors and industry leaders, wrapping up the weekend with a live pitch event in front of a panel of expert judges.

The event opened with inspiring talks from Aurore Hochard and Farah Frikha, Founder of Vesta Capsules and MEC alumna, followed by rapid-fire 30-second pitches and team formations. 

Throughout the weekend, participants learned how to identify customer needs, validate business concepts, and apply entrepreneurial thinking to solve real-world problems. 

Saturday focused on turning ideas into viable products and business models, with hands-on workshops including 鈥淏uilding the Startup Team鈥� led by Dr Rob Martin, Lecturer in Enterprise and Entrepreneurship at MEC. 

Tom Parson, Founder of Big Echo, led 鈥淏lank Page to Big Idea: Unlock Startup Ideas with AI鈥�, a session on using AI to spark creativity and accelerate the ideation process, helping students transform concepts into viable business ideas. 

Jorge Servert, Founder of Sensium, led 鈥淒eveloping the Right Product or Service鈥�, a practical session guiding students to define and build their product or service based on real market needs, while also creating their first business plan using MEC鈥檚 startup template. 

On Sunday, teams perfected their business ideas through sessions like 鈥淢arketing & Acquiring Customers鈥� with Eleni Chiarapini, Lecturer in Entrepreneurship at MEC, and 鈥淧ersonal Branding for Startups鈥� with Coralie Watson, Founder of Theme Socials. 

Lastly, students worked on their pitches in 鈥淧itch Perfect鈥� with Julia Spencer, Acceleration Manager at NatWest Corporate Banking. Julia shared industry experience and insight on what investors are really looking for in a pitch and how to make an idea stand out. 

The weekend wrapped up with final presentations to a judging panel featuring Professor Lee Pugalis (Deputy Director of MEC), Travis Ralph-Donaldson (Innovation Discovery Manager at the University鈥檚 Innovation Factory), Stephen Sankson (Regional Director at NatWest Corporate Banking), and Jenny Oliver (CEO and Founder of Biora Nature Tech). 

The event concluded with an awards ceremony recognising the top-performing teams and their innovative ideas:

First place went to Veila, a clothing brand redefining modest fashion, led by Sabrinel Takheroubt (AMBS, Faculty of Humanities) alongside Nishita Chatlani, Yutong Song, Danna Casta帽eda, and Eleanor Alphonso (all AMBS and Faculty of Humanities students). The team received 拢3,000 to continue their journey to market, focusing on direct-to-consumer growth and online marketing. 

Second place was awarded to DecoRent, a decoration rental service for short-term stays in 野狼社区. The team, Stella Zhuoyue Ji Chen (AMBS), Mollie Levitt (School of Arts, Languages and Cultures, Faculty of Humanities), Benya Irlam (AMBS), Yaowen (Stephen) Hu (AMBS), and Chaerin (Devon) Son received 拢2,000 to help expand their mission of bringing cosy, functional spaces to students across the city. 

Highly Commended went to isitUp, a speculative market app for investing in people鈥檚 relationships, led by Isaac Batho (School of Engineering).

In total, 20 new business ideas were formed over the weekend, showcasing the entrepreneurial energy of 野狼社区鈥檚 student community and representing students from across all three faculties, Humanities; Science and Engineering; and Biology, Medicine and Health. 

Throughout the weekend, participants were supported by a dedicated group of mentors offering one-to-one advice and feedback, including Oladabola Babalola (Babz), Fernando Torres, Harry Panter, Sergio Gutierrez, Luke Marden, Jonghun Lee, Rick Watson, Ramin Esmaeilzadeh, Huw James, and Leigh Wharton. 

About the Masood Entrepreneurship Centre:  

The Masood Entrepreneurship Centre (MEC) is the University of 野狼社区鈥檚 focal point for enterprise and entrepreneurship teaching, learning, and startup support. MEC helps students, researchers, and alumni turn ideas into real-world impact through workshops, mentorship, and venture programmes.  

Learn more at:  

This list coincides with the publication of the Home Office鈥檚 report on the statistics of scientific procedures on living animals in Great Britain in 2024. 

The ten listed organisations were responsible for 1,379,399 procedures, 54% (more than half) of the 2,637,578 procedures carried out on animals for scientific research in Great Britain in 2024*. Of these 1,379,399 procedures, more than 99% were carried out on mice, fish, rats, and birds and 82% were classified as causing pain equivalent to, or less than, an injection. 

The ten organisations are listed below alongside the total number of procedures they carried out in 2024. Each organisation鈥檚 name links to its animal research webpage, which includes more detailed statistics. Case studies explaining how animal research has been used in recent medical research are also provided in the Notes to Editors section. This is the tenth consecutive year that organisations have come together to publicise their collective statistics and examples of their research.

Seventy-two organisations have proactively published their 2024 animal research statistics

UAR has also produced a list (see appendix) of 72 organisations in the UK that have publicly shared their 2024 animal research statistics. This includes organisations that carry out or fund animal research.

All organisations are committed to the ethical framework called the 鈥�3Rs鈥� of replacement, reduction and refinement. This means avoiding or replacing the use of animals where possible, minimising the number of animals used per experiment and optimising the experience of the animals to improve animal welfare. However, as institutions expand and conduct more research, the total number of animals used can rise even if fewer animals are used per study. 

All organisations listed are signatories to the , which commits them to being more open about the use of animals in scientific, medical and veterinary research in the UK. More than 130 organisations have signed the Concordat, including UK universities, medical research charities, research funders, learned societies and commercial research organisations.

Wendy Jarrett, Chief Executive of Understanding Animal Research, which developed the Concordat on Openness, said: 鈥淎nimal research remains a small but vital part of the quest for new medicines, vaccines and treatments for humans and animals. Alternative methods are increasingly being phased in, but, until we have sufficient reliable alternatives available, it is important that organisations that use animals in research maintain the public鈥檚 trust in them. By providing this level of information about the numbers of animals used, and the experience of those animals, as well as details of the medical breakthroughs that derive from this research, these Concordat signatories are helping the public to make up their own minds about how they feel about the use of animals in scientific research in Great Britain.鈥� 

Dr. Maria Kamper, Director of the Biological Services Facility at The University of 野狼社区, said:

"Scientific research involving animals remains essential in advancing our understanding of health and disease, and is fundamental to developing new medicines and medical technologies.

"At our institution, we prioritize transparency in animal research alongside a culture of exceptional care among our staff. Our approach is founded on collaboration and superior animal husbandry standards. We are dedicated to cultivating a sustainable environment where animal welfare, staff wellbeing, scientific excellence, and open communication with both stakeholders and the public are our highest priorities.

鈥淭his dedication aligns with the University of 野狼社区's broader mission to enhance education, knowledge, and wisdom for society's benefit.鈥�

Case study:

Clotbuster drug is new hope for stroke treatment

A new clotbusting drug tested on mice has been shown by University of 野狼社区 scientists to be significantly better at treating ischemic stroke than existing therapies.

The compound, developed by the scientists and known as caADAMTS13, could be a breakthrough for patients who have brain blood clots with an overabundance of platelets- the tiny cell fragments that help form clots and are often not treatable by existing therapies.

野狼社区鈥檚 Dr Elizabeth Dalgarno celebrated when she heard the Government had decided of the 2014 Children Act, which said involvement of both parents would improve their children鈥檚 welfare, creating unsafe contact arrangements 

The decision follows years of advocacy and research and acknowledges the devastating impact the presumption had on victims:  the mothers and their children.

 Further changes put forward will also automatically restrict parents convicted of rape resulting in the birth of a child and for those convicted of serious sexual offences against any child鈥攏ot just their own- from having access to children. 

And parents convicted of abuse can no longer make decisions about a child鈥檚 schooling, medical care, or travel, removing the burden on survivors to apply through the family courts to provide immediate protection post-sentencing. 

Dr Dalgarno is also the Director and Founder of a collective of multidisciplinary professionals working in health, human rights, law, finance, social care and domestic abuse researchers. 

Her research  highlighted the urgent need for systemic reform, and included a study of the shocking impact of family courts on women鈥檚 health.

Another study, reported in the , revealed how nine dads accused of child sex abuse won parental access.

She said: 鈥淲e are overwhelmed with the extraordinary news that the presumption of parental involvement is to be revoked.

鈥淭his marks a historic and long-awaited moment of justice for victims of domestic abuse across the country.

鈥淲e would like to send our deepest gratitude to the many researchers and professionals - and the wider academic and survivor communities - whose tireless efforts have illuminated the harms and helped build the case for reform.鈥�

鈥淟ed by Claire Throssell, who turned unimaginable personal tragedy鈥攖he loss of her sons Jack and Paul鈥攊nto powerful advocacy that has shaped national policy.鈥�

She added: 鈥淚 also pay tribute to SHERA founder members, especially Natalie Page of The Court Said, Survivor Family Network, and Eight Street LLP, who have dedicated over a decade of their lives to this cause.

鈥淭he Victims and Courts Bill amendments follow a long-standing campaign led by Natalie Fleet MP, Baroness Harman, and Jess Asato MP.

鈥淎nd we also recognise the unwavering commitment of Dr Adrienne Barnett of Brunel University and Dr Charlotte Proudman of Right to Equality, whose legal and academic leadership has been instrumental.

鈥淎bove all, we thank the victim-survivors who have shared their stories, fought for justice, and dedicated their lives to this cause. There is much more work to be done, but this victory should be celebrated and belongs to you.鈥�

Dr Dalgarno also thanked Professor Arpana Verma, Alex Davies-Jones MP, Josh Barbarinde MP, Dr Marie Tidball MP,  Josh Fenton-Glynn MP, Alison Hume MP and Jess Phillips MP, the Domestic Abuse Commissioner, the London Victims鈥� Commissioner, Women鈥檚 Aid, Profs Birchall, Hester, Kelly and Choudhry, CWA, Kaleidoscopic, PEEPSA, Rights of Women, FiLia Hague Mothers and all those across the VAWG sector who have long advocated for these changes.

And now an upgraded version of the programme called Thumos,  involving small group workshops and a follow-up 1:1 phone or video call with the workshop facilitator afterwards, who is a psychological therapist, is being  trailed. 

The programme aims to equip medical students  with psychological strategies which some people find helpful. 

As the study is a trial, 50% of participants will be allocated to receive the intervention, 50% will not receive the intervention, but all participants can continue to access all other support services as usual. 

All participants will be asked to complete questionnaires and will be reimbursed for their time in completing follow up questionnaires (those which come after the first set/the baseline measurement). 

The 115 students, from medical schools across the UK, completed the original Reboot  coaching programme as part of a study to assess whether it would improve their psychological resilience, depression, burnout and confidence in their ability to cope with stressful work-related events. 

Before, during and after the coaching, the students were assessed in each of these areas.  found that taking part in Reboot was linked with significant improvements in all areas, with fewer students experiencing depression symptoms after they had completed the coaching. 

It was originally designed by Clinical Psychologist Dr Judith Johnson, formerly from the University of Leeds but now from The University of 野狼社区. 

Dr Johnson adapted the programme to fit the needs of medical students. Globally, one in two report high burnout, while one in three experience elevated depression. 

She said: 鈥淯ntil now, most evaluations of supportive interventions for medical students have focused on generic interventions such as mindfulness, stress management training and yoga. These lack relevance for medical students and professionals and there is no clear evidence for such interventions improving depression or burnout among this group. 

鈥淧oor mental health in medical students is a significant problem globally and there is evidence that a significant proportion of medical students intend to leave the profession as soon as they qualify.

鈥淭here is also a workforce crisis, with projections indicating a global shortage of around 10 million healthcare professionals by 2030. Anything which can help retain healthcare professionals in their professions is sorely needed. 

鈥淲e found reboot supported medical students with work-related stressors, normalising the anxiety which is inherent to training, providing peer-support and also helping medical students develop skills and solutions for the challenges they face and will continue to face as qualified doctors. 

• If you are a medical student in a year involving clinical placements, such as Y4 or Y5 you are eligible to take part in a new study evaluating a supportive programme designed to help students cope with the challenges placements can present. To express interest visit
• For more information, email ThumosTrial@manchester.ac.uk or the Principal Investigator Dr Judith Johnson,Judith.johnson@manchester.ac.uk

The report models the potential effectiveness of the Government鈥檚 鈥楪etting Britain Working鈥� programmes, showing these savings could be made by the end of this Parliament in 2029 if just 5% of out-of-work people in receipt of Universal Credit returned to work.

The report estimates that:

• Getting 5% of unemployed under-25s back into work would save 拢903 million.
• Getting 5% of under-25s workless due to sickness or disability back into work would save 拢631 million.
• Getting 5% of unemployed over-25s back into work would save 拢6.67 billion.
• Getting 5% of over-25s workless due to sickness or disability back into work would save 拢11.9 billion.

The 5% estimate is based on what happened with the similar New Deal initiatives that happened in the UK in the 2000s. Savings would be made in the form of both reduced benefits spending and increases in tax and national insurance revenue.

The costs to Government of assisting this number of people back into, and helping them stay in, employment could be between 拢1.5 to 拢1.9 billion. So that within just two years, the Government could save almost 拢10bn, meaning every 拢1 invested in employment support programmes could return between 拢5.21 and 拢6.63.

Currently, more than five million people in the UK are out of work and in receipt of Universal Credit - including almost one million people aged 18-24 years who are not in education, employment or training (NEETs). 1 in 5 of these young people receive health-related benefits largely for mental health conditions. Ill-health related economic inactivity accounts for over three million claims and is particularly concentrated in the most deprived and deindustrialised areas. As of May 2025, the average household on Universal Credit received 拢961.63 per month in England.

The report was commissioned and funded by the Work and Pensions Select Committee and produced by Health Equity North with academics from Newcastle University, The University of 野狼社区, University of Liverpool, and University of Glasgow.

The UK government has introduced several return-to-work initiatives over the last 12 months as part of its desire to 鈥楪et Britain Working鈥�. This includes:

• Creating a new Jobs and Careers Service by merging Jobcentre Plus and the National Careers Service
• Establishing eight 鈥淭railblazer鈥� areas that receive funding to test local partnerships between the NHS, councils, colleges, and employers
• A Connect to Work programme providing rapid job-matching, training, and in-work coaching
• Embedding employment advisers in mental health and musculoskeletal services, with expanded Individual Placement and Support provision.
• Launching a new Primary Care pilot will enable GPs to directly refer patients for employment support.
• Launching proposals for the Employment Rights Bill and the NHS 10-Year Plan鈥檚, which focus on prevention will further reduce ill health among working-age people.
• The Youth Guarantee for NEETS, which ensures access to apprenticeships, training, education, and tailored job support - including paid work placements for those out of work for more than 18 months.

These schemes replicate previous New Labour successes of the 鈥楴ew Deal鈥� return to work programmes which, between 1997 and 2010, saw a spike in employment across all age groups. This saved up to 拢2,500 per New Deal participant, with 46% gaining a job and 27% sustaining employment that lasted six months or more.

The report has been submitted as evidence to the Government鈥檚 Work and Pensions Select Committee, which looks into the policies and spending of the DWP, including benefits for people both in and out of work.

Debbie Abrahams, MP for Oldham East and Saddleworth and Chair of the Work and Pensions Select Committee, said: : 鈥淎fter more than a decade of austerity-driven policies - further compounded by the COVID-19 pandemic - levels of ill health and health inequalities have deteriorated across the UK, but particularly especially in deprived areas. As a result, the country now faces significantly higher rates of economic inactivity due to ill health compared with similar economies such as Germany, Sweden, and France. This poses a major economic challenge, contributing to stagnant growth, widening productivity gaps, and increasing poverty and health inequalities. In the past we have seen the value of supportive welfare-to-work programmes, such as the New Deal for Disabled People and New Deal for Young People, which addressed the needs of the whole person in helping them to get into work. It鈥檚 imperative that these Government 鈥楾railblazer鈥� schemes are ramped up 鈥� if we can get even a small proportion of the out-of-work population working again, we will see extraordinary gains, not only fiscally, but for these individuals, their families and across communities, workplaces, and public services alike.鈥�

Professor Clare Bambra, Academic Co-director of Health Equity North and Professor of Public Health at Newcastle University, said: 鈥淐onstituencies such as East Marsh and Port, Grimsby, Central Easterhouse, Glasgow and Birkenhead Central have around 30% of the working-age population receiving ill health-related welfare benefits. In these areas, life expectancy is 12 years less than the national average. This stark inequality reflects the deep connections between health, work, and place - where decades of industrial decline and underinvestment have left communities struggling with poor health, limited opportunities, and persistent economic disadvantage.

鈥淏y embedding employment support within health services and targeting investment where ill health and unemployment overlap, we have a real opportunity to break this cycle. Helping even a small proportion of people in these areas back into good, secure work could have transformative effects - not just for the government and local economies, but for people鈥檚 health, wellbeing, and prosperity.鈥�

Dr Luke Munford, Academic Co-director of Health Equity North and Senior Lecturer in Health Economics at The University of 野狼社区, said: 鈥淲hen people are supported to stay healthy, skilled, and connected to good jobs, everyone benefits 鈥� be it individuals, families, businesses or the economy as a whole. This report highlights the value of investing in people鈥檚 health and employability. Even modest improvements in getting people back into the workplace could deliver billions in savings by the end of the decade. These findings show that the Government鈥檚 efforts to integrate and embed health and employment can be a huge step towards the economic recovery of the UK.鈥�

Dr Andy Baxter, Research Associate at the University of Glasgow, said: 鈥淓mployment is one of the strongest determinants of health. When people are in good, secure work, they鈥檙e less likely to experience long-term illness, more likely to engage with preventive healthcare, and more connected to their communities. Reducing economic inactivity through health-focused employment programmes provides stability, purpose, and the foundation for healthier, fairer futures. Effective back-to-work schemes are crucial in rebuilding a Britain that is healthy and prosperous, and our research shows that the return on investment potential is huge.鈥�

Hannah Davies, Executive Director of Health Equity North, said: 鈥淲e鈥檝e seen in the past that well-designed back-to-work schemes can transform lives and deliver real results for both people and the economy. But this time, it needs to be right from the very start - ensuring programmes are properly funded, evidence-based, and tailored to the needs of local communities. If the Government can combine effective employment support with investment in health, skills, and opportunity, they have a genuine chance to break the cycle of long-term unemployment and ill health once and for all.鈥�

Read the full analysis 鈥楨stimating the savings and financial benefits to the UK government of return-to-work for people in receipt of Universal Credit鈥� here:

11 student and graduate founders from across The University of 野狼社区 gave compelling 4-minute pitches to an audience of investors, local ecosystem partners, stakeholders, and peers 鈥� demonstrating innovative solutions to real problems across diverse sectors. 

They each developed their products and services on the 野狼社区 Venture Builder 鈥� MEC's 12-week programme of structured support to help entrepreneurs test and validate their idea, build an MVP and gain real traction on their journey to market-readiness. 

Mohamed Abbas (Venture Builder Manager, MEC) emphasised the importance of collaboration between organisations and individuals in supporting emerging young founders:

After the pitches, startups and guests gathered for the showcase and networking 鈥� an opportunity to ask questions, share ideas, and build connections. 

The ventures showcased were: 

• SpinOr 鈥� Compact superconducting quantum computers.
• PeerMatch 鈥� Building the platform where humanity's next breakthrough begins.
• AquaMinds 鈥� AI-powered early warning system for fouling in water treatment plants.
• Vesta Capsules 鈥� Offering safe sleep anytime, anywhere through stackable, weatherproof, and modular pods inspired by Japanese capsule hotels.
• ARDHANN 鈥� AI-powered next-gen composite materials for Energy, Space and Defence.
• Gynomics 鈥� Harnessing computational biology and machine learning to drive predictive and preventative care in women's reproductive health.
• Ecotrace 鈥� Plug-and-play circularity SaaS to extend the lifecycle of consumer goods, improve customer experiences, and help manufacturers meet tightening regulations.   
• Synkit 鈥� Wellness app helping employers support female staff through cycle-synced lifestyle.
• Waddle 鈥� Spontaneous small-group meetups for students seeking real-world connection.
• UniSights 鈥� Platform for Latin American schools to connect students with UK universities.
• TerraIQ 鈥� AI-powered farm optimisation platform for smallholder farms to unlock sustainability-linked revenue. 

We would like to congratulate all the startups who participated in the Demo Day for reaching this key milestone and we are excited to follow their growth and continued success. 

MEC is the University鈥檚 focal point for enterprise and entrepreneurship, offering opportunities for all current students, recent graduates and staff. Our vision is to create an ecosystem that nurtures innovators and fosters startups, driving global impact. 

You can find out more on our website . If you are interested in supporting our entrepreneurs with your expertise or investment, please get in touch with our team.

The knowledge could reduce the risk of severe bowel complications from radiotherapy, known as rectal toxicity, heralding a more personalised approach to prostate cancer treatment. 

The study, funded by Prostate Cancer UK, is published in Clinical Cancer Research today.(13/10/25). 

The study was led by PhD researcher Artemis Bouzaki from The University of 野狼社区, who is also an honorary researcher at The Christie NHS Foundation Trust. 

Her approach is the first study to combine genetic data with detailed spatial maps of where radiation is delivered in the rectum. 

Though scientists have already identified the lower posterior of the rectum as significant for rectal toxicities after prostate cancer radiotherapy, the study is the first to incorporate genetic information into the framework. 

鈥�Rectal toxicity is a significant concern for patients receiving radiotherapy for prostate cancer, the most common cancer in men and  now the most common cancer in England,鈥� she said.

鈥淎lthough dose guidelines limit the overall rate of rectal toxicity to around 10%, bowel function nevertheless often deteriorates over the course of treatment and beyond.

鈥淪ome patients experience severe, persistent complications, such as incontinence, or rectal bleeding, permanently affecting their quality of life.鈥�

The scientists analysed data from 1,293 prostate cancer patients as part of the international REQUITE study, which collected radiotherapy outcomes from 17 hospitals in Europe and the USA between 2014 and 2016.

For each of three genetic variants linked to increased radiation sensitivity, patients were grouped based on whether they carried the variant.

They were analysed alongside dose maps over the surface of the rectum - based on a methodology developed by the team in their earlier work- which showed the risk regions were consistently in the lower posterior rectum.

 The scientists used a special way of analysing 3D image data by looking at it in tiny volume units called voxels, the 3D equivalent of a pixel.

Instead of just measuring overall dose averages in a region, Voxel Based Analysis analyses the data voxel by voxel across the entire image. This allows smaller regions of organs to be identified, where more radiation dose is linked to different treatment side-effects.

Co-author and supervisor of the study, Dr Alan McWilliam from the University of 野狼社区 added: 鈥淥ur work has revealed that patients with certain genetic variants may benefit from lower radiation doses in those specific parts of the rectum, which could make a significant difference to their recovery.

鈥淗owever, these findings are preliminary, and clinical studies will be necessary to confirm their safety and effectiveness before any changes are made to standard treatment.鈥�

One reason why the lower part of the rectum may be particularly sensitive is that the higher and lower parts of rectum have anatomical and functional differences which could influence their response to radiation.

The differences play a key role in inflammation and immune response and are likely to be affected by different genetic variants, including the ones analysed by the researchers.

Dr Hayley Luxton, Head of Research Impact and Engagement at Prostate Cancer UK, said: 鈥淣o two men鈥檚 prostate cancers will be the same, and different men will opt for different treatment. We know that radiotherapy is an extremely effective way to treat men with prostate cancer. However, it can have life changing side effects for patients.

鈥淭here are two ways to limit the side effects caused by radiotherapy 鈥� either through adjusting dosage to account for genetics or by reducing the dose to certain areas of the body.

鈥淔or the first time, thanks to Prostate Cancer UK鈥檚 funding alongside Movember, the team in 野狼社区 have combined both methods, and can now fine-tune the delivery of radiotherapy based on a man鈥檚 genetics.

鈥淭he ability to personalise treatment in this way is exactly the direction we want prostate cancer care to head in. This study helps bring us that much closer to making sure the right men get the right treatment, at the right time.鈥�

The paper Integration of dose surface maps and genetic data identifies the lower posterior rectum as a key region for toxicity after prostate cancer radiotherapy, DOI: xxxxxxxxxxxx is available

The study, published in , funded by Wellcome and the Royal Society, definitively confirm the mother鈥檚 role as central to the emotional wellbeing of the family unit.

Though other researchers have focused on isolated relationships between mother and child, this is the first study of the role that both partners may play in family mental health, both concurrently and over time.

The researchers produced a series of maps - called networks - depicting the way symptoms of anxiety and depression in parents and their children up the age of 16 connect with each other over time.

They based the analysis on data from 3,757 families from the UK Household Longitudinal Study between 2009 to 2022.

Additional cross-sectional network maps of 8,795 families captured independent associations between family members鈥� mental health.

While fathers鈥� emotional state was linked to mothers鈥� mental health in the cross-sectional analysis, they observed an absence of associations with their children.

However, they reported that fathers鈥� emotional symptoms may influence children鈥檚 well-being indirectly, by affecting maternal mental health.

The longitudinal maps also identified how a mother鈥檚 feelings of being overwhelmed affected the child鈥檚 emotional state鈥攅specially worry, and that children鈥檚 feeling of worry cycled back, further affecting her own emotional health.

The influence of maternal emotional health on their children waned as they got older, reflecting how adolescents transfer their primary attachment from their parents to others.

Lead author Dr Yushi Bai from The University of 野狼社区 said: 鈥淲e do know that children鈥檚 mental health is formed by, and within, their family through shared genes, nurturing behaviours of caregivers, and sibling dynamics.

鈥淥ur study identified mothers, not fathers, as central to the emotional wellbeing of the family unit.

鈥淲e suspect that this can be explained by traditional division of parenting roles, where societal expectations often position mothers as the primary caregivers and organisers within families.

鈥淢others are typically more involved in child-rearing and spend considerably more time with their children than do fathers, which means they are more likely to influence children鈥檚 lives and development.

鈥淕reater exposure to maternal care might also lead children to copy their mother鈥檚 coping mechanisms and behaviours.鈥�

Co-author Dr Matthias Pierce from The University of 野狼社区 said: 鈥淓motional disorders in young people are not only increasingly prevalent, but also present at early ages, highlighting the need for early intervention and prevention.

鈥淕iven the family鈥檚 central role in shaping and sustaining mental health, interventions and policies should consider how the family mental health ecosystem operates.

鈥淭his study shows the potential value of interventions that aim to support mothers and reduce maternal anxiety, which may have the greatest impact on improving family dynamics and reduce the risk of poor mental health in children.

鈥淲e also suggest that the link between fathers鈥� and mothers鈥� mental health presents a further potential avenue for alleviating maternal stress.鈥�

• The paper Quantifying cross-sectional and longitudinal associations in mental health symptoms within families: network models applied to UK cohort data  published in MBJ Open is published

• doi.org/10.1136/bmjopen-2025-104829

The high-tech hearing tests, they say, can efficiently understand human speech from the comfort of your own home, rather than at a hospital clinic, by using AI to screen out background noise.

The researchers developed and tested an AI-powered version of the Digits-in-Noise (DIN) test that combines text-to-speech (TTS) and automatic speech recognition (ASR) technologies.

The result was a fully automated, self-administered hearing test that can be performed without clinical supervision in 10 minutes.

The study, funded by a Medical Research Council鈥檚 Doctoral Training Partnership grant, could revolutionise the way hearing tests are carried out and is published today  in the journal Trends in Hearing.

Lead author Mohsen Fatehifar from The University of 野狼社区 said: 鈥淗aving tested this technology, we are confident that with the help of AI it is entirely possible to automate a hearing test on a computer or smart phone so it can be done from the comfort of your own home.

鈥淭hough we still need more extensive trials and a user-friendly interface, this technology could potentially make a huge difference to patients.

鈥淪pecialised equipment in the clinic and the specially trained staff who are needed to use it are not always available to patients who need quick assessment.

鈥淎dditionally, people are slow to seek help when experiencing hearing difficulties: there is an estimated delay of 8.9 years between the time hearing aids are needed to the time of their adoption.

鈥淭hat is why we are excited about the ability of this system to incorporate machine learning into the test procedure to make it less dependent on human supervisors.鈥�

Speech-in-noise tests are commonly used to detect hearing problems by assessing how well someone can understand spoken speech over background noise.

Traditional tests typically rely on pre-recorded human speech and require a clinician to score the responses.

However, the AI-powered version replaces both with computer generated speech and automatic speech recognition, allowing the test to run entirely on its own.

In a group of 31 adults, some with normal hearing and with hearing loss, the AI-powered test was evaluated against two conventional DIN tests.

The researchers assessed both reliability - how consistent results were across multiple runs and validity - how closely results matched a reference test.

Results showed that the AI-powered test gave virtually the same results as the conventional DIN tests.

While there was slightly more variability in some cases - especially in people with a strong accent- the overall reliability and accuracy were the same, demonstrating the addition of AI did not negatively impact test performance.

And by using larger ASR systems, the researchers say the higher accuracy would make the system compatible with stronger accents.

Co-authors Professor Kevin Munro and Michael Stone are from The University of 野狼社区 and supported by the National Institute for Health and Care Research (NIHR) 野狼社区 Biomedical Research Centre.

Professor Munro said: 鈥淭his  study highlights how AI can make hearing tests both reliable and user-friendly, particularly for individuals who may find traditional formats鈥攕uch as keyboards or touchscreens鈥攃hallenging to use.

鈥淚t also marks an important step toward more personalised and accessible hearing assessments that people can complete independently at home.

鈥淭he test software will be freely available, providing a foundation for future developments using more advanced speech technologies.鈥�

Professor Stone said: 鈥淭his research highlights the potential for well-crafted and tested AI to modernise hearing care.

鈥淥ur team plans to explore extending this technology to more complex speech tests in future studies.鈥�

Using sunbeds causes melanoma and other skin cancers, particularly among young people, yet existing sunbed legislation is ineffective and there is little evidence that stricter rules would help protect the most vulnerable, say Professor Paul Lorigan and colleagues. 

Indoor tanning is experiencing a boom in popularity, particularly among Gen Z (born 1997-2012), with social media promoting sunbeds as integral to wellness, they explain. For example, a 2024 survey of 2,003 people in the UK by Melanoma Focus found that 43% of respondents aged 18-25 used sunbeds, half of them at least weekly, with many unaware of the associated dangers. 

And despite a ban on under 18s using sunbeds in England and Wales in 2011, a 2025 survey by Melanoma Focus of 100 UK 16-17 year olds found that 34% were still using sunbeds. 

Neither the number nor location of sunbed outlets in the UK are monitored, point out the authors. Data from websites and social media in January 2024 identified 4,231 sunbed outlets in England and 232 in Wales, with density per 100,000 population highest in north west and north east England and in the most deprived areas. 

The distribution of sunbed outlets also correlates with melanoma rates in young people, with the highest rates in north England, they add. Over 2,600 new diagnoses were recorded annually in 25-49 year olds in England during 2018-20 and 146 deaths, with two thirds of cases in women. 

Regulation has also failed to prevent young people鈥檚 use of sunbeds in other countries, they note. For example, the percentage of under 18s using sunbeds in the Republic of Ireland has barely changed since stricter regulation in 2014, while Iceland鈥檚 15-17 year olds are now the main users of sunbeds despite a ban for under 18s in 2011. 

The current situation in the UK is 鈥渁 clear example of an under-regulated industry aggressively marketing a harmful product to a vulnerable population,鈥� they write. 鈥淎n immediate outright ban on commercial sunbeds alongside public education offers the most cost effective solution to reduce skin cancer, save lives, and ease the burden on the NHS.鈥� 

To counter the economic impact of banning sunbeds on providers and communities, they suggest use of a buy-back scheme 鈥渢o mitigate industry pushback and the potential effect on livelihoods.鈥� 

They conclude: 鈥淭he UK government has pledged to prioritise prevention and to reduce health inequalities. Commercial sunbeds target those who are most disadvantaged and susceptible to harm.鈥� 

鈥淓nhanced efforts to encourage sun safe behaviours are critically needed but will likely take a generation to have an effect. A ban on commercial sunbeds is the first step in this process. It would send a clear message and have an immediate effect on skin cancer.鈥�

• Analysis: Commercial sunbeds should be banned in the UK  is published in the BMJ doi: 10.1136/bmj-2025-085414 and is available

Current treatments for asthma largely involve controlling the inflammation of lung tissue using steroid inhalers. However, 4 people die every day in the UK¹ from asthma related complications. With funding from the Medical Research Foundation and Asthma UK, a team of researchers from the University of Aberdeen and the University of 野狼社区 have investigated the scarring that occurs in lung tissue as a result of asthma and have been able to reverse these changes in animal models.

Although still in the early stages of development, this discovery paves the way for a new way to treat not only asthma, but many different diseases in which similar structural changes in tissues occur. Such diseases include conditions like chronic obstructive pulmonary disease (COPD), chronic heart disease and cirrhosis of the liver and account for approximately 40% of deaths worldwide.

Asthma affects more than 7 million people in the UK and severe asthma can have a hugely detrimental impact on an individual鈥檚 quality of life. Even when treated, asthma can be fatal and the most recent data shows it contributed to 1,465 deaths in the UK in 2022¹ 鈥� this is despite the availability of new treatments which aim to dampen down inflammation in the lungs.

However, as well as inflammation, asthma also results in what has previously been considered to be irreversible structural lung changes. These changes include making the lungs stiffer and more scarred through increases in things like 鈥榚xtracellular matrix collagens.鈥�

Using animal models that share features of severe asthma in people, the researchers found that preventing inflammation alone is not enough to reverse this tissue scarring. Instead, they found that blocking the action of specific protein molecules strongly associated with inflammation and tissue damage, 鈥榬emarkably reversed鈥� scarring in the lungs. 

Dr Tara Sutherland, Lecturer of Immunology, who led the research at the University of Aberdeen, alongside collaborators at the University of 野狼社区, explains: 鈥淒rugs that inhibit inflammation in asthma are crucial for managing the disease. However, these drugs may not always be enough to prevent and reverse lung damage found in severe asthma.

鈥淥ur findings show that we also need to consider that structural lung changes occur in severe asthma and that these changes may occur independently of inflammatory pathways.

鈥淎 better understanding of these structural changes and their consequences for lung health could lead to development of new therapies that benefit people particularly with severe asthma and could potentially be used alongside drugs that stop inflammation.

鈥淎lthough a first step in a long process, our study suggests avenues for new treatments that may have the potential to prevent disease progression and even reverse tissue scarring in asthma and many other diseases where fibrosis due to disorganised matrix formation is suggested to account for approximately 40% of worldwide mortality.鈥�

James Parkinson, Research Associate from the division of Immunology and Immunity to Infection and Respiratory Medicine at the University of 野狼社区 who collaborated on the project added: 鈥淭his work adds a new layer to our understanding of how asthma develops. It also reinforces the importance of considering all aspects of airway remodelling when evaluating future potential therapies.鈥�

, CEO of the , said: 鈥淎sthma affects millions of people in the UK, including 1.1 million children, yet despite current treatments, too many people still die from the condition every day. Severe uncontrolled asthma can cause lasting damage to the lungs and drastically reduce quality of life. This research is a crucial step forward 鈥� showing how we might not only prevent that damage, but even reverse it, opening the door to treatments that could transform lives.

鈥淏y supporting studies like this, the Medical Research Foundation aims to generate the evidence needed to change how asthma is treated and ultimately improve outcomes for people living with the condition.鈥�

Dr Ellen Forty, Research Networks and Partnerships Manager at Asthma + Lung UK added:

鈥淎sthma + Lung UK is pleased to have funded this exciting research which has helped to tease apart some of the ways that damage to lung tissue occurs in severe asthma, showing potential that some aspects of the damage could actually be reversed in mice. Now we need to invest in the next stages of this research to better understand this newly discovered process, and whether it works the same way in humans.

鈥淭his study offers hope for a new avenue for future treatments for the 7.2 million people in the UK living with asthma, that could supplement existing medicines. It could also have benefits for those with other lung conditions with similar causes of damage. Funding for lung health research is on life support and urgent action is needed to increase investment.鈥�

This research was funded by the Medical Research Foundation and the Asthma and Lung UK Fellowship with support from Medical Research Council and Wellcome.

1: 

鈥淗owever, if we want to create high streets that truly support healthier, fairer communities, we must also invest in bringing back vital amenities like libraries and community hubs - regulating unhealthy outlets is important, but we also need to create positive alternatives that give people better choices. The Prime Minister鈥檚 announcement is progress, but now we need some real ambition."

This success highlights the importance of academic research in tackling some of society鈥檚 most pressing challenges. As the government takes steps to empower local authorities, the researchers will continue to work with policymakers, communities and partners across the UK to ensure that high streets can once again thrive as healthy, inclusive spaces.

The report calls for urgent reforms, including:

Faster approvals 鈥� cutting the red tape that slows NHS trial delivery.
Flexible design 鈥� letting participants choose between home visits, clinic appointments or online check-ins.
Specialist centres 鈥� building dedicated hubs for mental health trials inside major NHS Trusts.
Smarter promotion 鈥� using social media campaigns and testimonials to boost awareness and trust.

Despite the surge of private providers, the NHS still has key advantages. It can draw on huge, reliable patient datasets and long-standing doctor-patient relationships that private firms cannot match. This helps ensure trials include a diverse mix of people 鈥� and prevents the problem of 鈥減rofessional patients,鈥� which industry leaders say can account for up to 30% of participants in US depression trials.

The study was supported by the UK Government鈥檚 Office for Life Sciences and the National Institute for Health and Care Research.

Established in 1945, COEH is the UK鈥檚 oldest and one of the world's earliest centres for occupational health research and education. Its foundation lies in 野狼社区's industrial history, particularly the cotton industry, with early studies addressing respiratory diseases and lead exposure. 

The annual honours , the first Professor of Occupational Medicine (1945鈥�1964). The Centre鈥檚 subsequent leaders have each contributed to its growth and enduring reputation: Tommy Scott focussed on research on bladder cancer and hearing loss; Tim Lee broadened the scope to areas such as occupational asthma and lead poisoning, and introduced distance learning; Nicola Cherry expanded the department further with research into neurotoxicity and Gulf War Syndrome, launching the Occupational Disease Ascertainment Network (ODIN) network; and Raymond Agius strengthened environmental health research and online education, securing long term funding for the future. 

Current lead, Professor Martie van Tongeren, has transformed the Centre into an interdisciplinary centre offering innovative undergraduate and postgraduate training, attracting students from around the world. Working in collaboration with and the , COEH鈥檚 research spans global occupational and environmental health, health inequalities, climate change and health, digitalization and AI, as well as traditional occupational hazards. The Centre is also actively engaged with regulatory bodies, and its balance of basic and translational research supports policy makers. 

As COEH enters its ninth decade, the centre continues to build on its founders鈥� pioneering work while adopting new approaches to train practitioners and address emerging challenges. Through interdisciplinary collaboration with partners COEH remains committed to social responsibility and reducing health inequalities both in the UK and worldwide, continuing to make a significant impact. 

Professor van Tongeren commented: 鈥淚 am proud and honoured to be part of the Centre for Occupational and Environmental Health, continuing the legacy begun by Prof Ronald Lane 80 years ago. As new challenges like AI emerge and longstanding ones like silicosis persist, our mission to protect worker health through research and teaching remains vital. I鈥檓 confident COEH will continue to lead the way.鈥�

80^th anniversary event 

COEH invites colleagues and guests to commemorate 80 years of pioneering research and education at The University of 野狼社区 on the afternoon of 1 October. The event will bring together past and present staff, students, and guests to honour the Centre鈥檚 legacy and explore future progress in occupational health.  

The programme will include: 

• Lightning talks showcasing key achievements and ongoing research initiatives 
• Forward-looking panel session to explore challenges and opportunities in occupational health 
• The , presented by Professor Malcolm Sim, former Head of the Monash University Centre for Occupational and Environmental Health in Australia 
• Closing reception  

2025 Lane Lecture 

While UK occupational health research, including at COEH, now focuses more on stress and mental health, traditional risks such as occupational respiratory disease continue to be a key priority. The Centre has, in recent years, led efforts to address the dangers of artificial stone (used frequently in kitchen worktops and bathrooms) as workers without proper controls can develop accelerated silicosis鈥攁 serious lung disease affecting even young individuals. 

Professor Malcolm Sim played a lead role in research and advisory activities to address the silicosis epidemic in Australia among stonemasons working with artificial stone. In this year鈥檚 Lane Lecture, Professor Sim will explore artificial stone silicosis further through his talk, 鈥�The Artificial Stone Silicosis Epidemic: Lessons Learned for More Effective Prevention鈥�. 

where you can also find a detailed programme.

The peer reviewed meta-analysis of 16 studies involving 71,336 patients from the US, UK, and the Netherlands published in the today (10/09/25), is a wake-up call to policy makers grappling with escalating numbers affected by the disease. 

鈥淥ur study provides evidence of significant disparities in telemedicine use for type 2 diabetes among men, black communities and those with lower levels of education,鈥� said Nawwarah Alfarwan, a PhD researcher and lead author of the study. 

鈥淭hese groups already face many challenges in accessing essential healthcare services. 

鈥淓very 10 seconds, somebody dies from diabetes-related complications worldwide, most of whom have type 2 diabetes, so policymakers  really need to think about how to improve access to this crucial form of healthcare.鈥� 

Telemedicine has revolutionised the management of type 2 diabetes in primary care by improving access to healthcare services, and consequently health outcomes. 

Comprising a range of technology including virtual consultations, wearable devices, mobile health apps and other technologies, health services have successfully used it as a response to increasing prevalence of the disease. 

Data from 5 studies comprising 59, 609 patients showed patients with higher education levels had 68.1% greater odds of using telemedicine than those with lower education levels. 

The less educated, say the researchers, have lower levels digital and health literacy, and be more likely to have concerns about trust and privacy. 

Ten of the studies, comprising 68,355 patients, showed female patients had a 5% higher chance of using telemedicine than men.

The difference can be explained, say the researchers, by women being more actively engaged with healthcare services not only for themselves but also their family.

Existing epidemiological evidence, they add, suggests men鈥� have lower help-seeking behaviour, stronger preferences for in-person consultations, or lower levels of digital health literacy.

Five of the studies showed that compared to white patients, black patients were less 45% likely to use telemedicine.

Many people within black communities, the researchers argue, have limited access to digital infrastructure, mistrust in healthcare systems, language barriers, and inadequate insurance coverage or digital literacy support.

And 10 of the studies comprising 47 927 patients showed older patients were 2.1% less likely to use telemedicine than younger patients.

Co-author Professor Maria Panagioti , also from The University of 野狼社区,  added: 鈥淔or patients with type2 diabetes, we show the extent of the digital divide in certain demographics, especially those from minority backgrounds.

鈥淟ack of affordable access to computers, smartphone, and lower levels digital and health literacy all contribute to these inequalities.

鈥淏y understanding these disparities and addressing the underlying factors, policymakers could make more inclusive and effective telemedicine interventions.

鈥淭hey should also  consider targeted strategies to improve engagement among men, such as awareness campaigns and tailored interventions.鈥�

• The paper is Demographic and Socioeconomic Disparities in Telemedicine Utilisation Among Individuals with Type 2 Diabetes in Primary Care: Systematic Review and Meta Analysis is published in the  

The final version of the tool, called INSPECT-SR, is now published on the pre-print server . 

It was developed by a worldwide collaboration of more than 150 integrity and health research experts, led by Dr Jack Wilkinson from The University of 野狼社区 

Funded by the National Institute for Health and Care Research (NIHR), it was developed in collaboration with the University of Colorado Anschutz Medical Campus and Cochrane, a not-for-profit organisation which is the world鈥檚 leading publisher of health systematic reviews. 

Some of the studies are subject to critical but honest errors, but many appear to be fraudulent.

Concerns are growing over the increasing numbers of problematic high-level summaries of the research evidence from randomised controlled trials , known as systematic reviews. 

In 2023 alone, over 10,000 research papers issued globally were retracted by journals according to an analysis by , many of which used evidence from problematic RCTs. 

Dr Wilkinson warns problematic RCTs  can result in medical research potentially being compromised, drug development hindered and promising academic research jeopardised. 

INSPECT-SR is designed to root out problematic RCTs which publish faked or manipulated data or have Inadvertently made critical errors. 

Some, written for a fee by outfits known as 鈥減aper mills鈥�, are entirely fabricated. 

The tool guides users through a series of 21 checks, grouped into 4 domains:

• Post publication notices which express concern and retractions.
• conduct, governance, and transparency
• text and figures
• data discrepancies and statistical errors.

One of the most well-known examples of problematic RCT research was around claims the drug Ivermectin, hailed as a miracle drug that would save the lives of people with severe COVID-19. 

However, some of the trials used to make the Ivermectin claims appear to have been fabricated, according  health authorities in the . Subsequent high-quality trials suggested little or no benefit. 

In another example , the National Institute for Health and Care Excellence (NICE) reversed recommendation for a device called a fetal pillow, developed to assist caesarean sections, following the retraction of three clinical studies supporting it. 

According to an article in : An International Journal of Obstetrics & Gynaecology, a trustworthiness assessment may have prevented the use of the evidence in the NICE guideline, as it contained statistical anomalies. 

And trustworthiness concerns were also identified in a group of trials around the use of  CBT and exercise to combat spinal pain. The trials had substantial impacts on clinical practice guidelines. Several have now been .

Dr Wilkinson said: 鈥淲hen a systematic review is carried out, it includes all randomised  controlled trials on a given topic.

鈥淏耻迟 historically, there has been no way to identify fraudulent or otherwise problematic RCTs, meaning that these studies are inadvertently included in systematic reviews.

鈥淭his is a big problem, as systematic reviews are very influential - they inform health guidelines for example.

鈥淢ost fraudulent RCTs are produced by individual researchers rather than commercial paper mills, but with the  advent of  AI I fear  this is likely to become more of a problem in the future.鈥�

He added: 鈥淎cademic papers are often assessed for quality before they are published. But reviewers do not ask the more fundamental question of whether the evidence they are reading is even genuine..

鈥淏耻迟 we anticipate that INSPECT-SR will become the standard for assessing trustworthiness of RCTs, especially as it has been created withCochrane for use in their systematic reviews of health interventions.

鈥淗owever, it鈥檚 important to stress that our tool is not merely a test for fraud and misconduct-  though clearly many problematic studies are examples of that.

鈥淚t also tests for critical errors which is why our priority is to  determine if a clinical trial should be used to guide healthcare decisions.

鈥淲ork is ongoing to develop more automated systems -  perhaps using AI-  to assist with this process. In the future, we hope to expand our work  to detect problems in other forms of research studies, not just clinical trials.鈥�

• The paper INSPECT-SR: a tool for assessing trustworthiness of 1 randomised controlled trials is available on the print server https://doi.org/10.1101/2025.09.03.25334905

The work by Professors Jo Dumville and Nicky Cullum on the most effective types of compression treatments is good news for the hundreds of thousands of patients affected by venous leg ulcers every year,  costing the NHS tens of millions of pounds. 

Venous ulcers are a common long-term condition which adversely affect people's quality of life; nurses deliver the majority of care, which takes the form of compression therapy as a first-line treatment. 

According to the NHS National Wound Care Strategy Programme, venous leg ulcers account for 60% to 80% of all leg ulcers. 

However, the abundance of different compression treatments and heavy product promotion by the wound care industry makes it difficult for nurses to decide, with patients, on the course of treatment that is most clinically effective and offers the most value to the NHS. 

The guidance - known officially as a 鈥淟ate Stage Assessment" -  is set to change that by providing crucial information to nursing staff on the most effective types of compression. 

It will also help NHS commissioners and procurement specialists give healthcare professionals access to a range of the most appropriate compression products to ensure their affordability to the NHS. 

According to the researchers鈥� evidence, the clinical effectiveness of two-layer compression hosiery and two-layer and 4-layer bandages is similar, while compression hosiery is more cost-effective than bandages. However, compression wraps are less clinically and cost-effective.

Professor Cullum was first asked to review the research evidence on leg ulcer management by the then Department of Health (now the Department of Health and Social Care) in 1989.

Working with Professor Dumville, they have been analysing and publishing the evidence in Cochrane and other systematic reviews, and have worked to fill knowledge gaps by doing new randomised controlled trials and other relevant studies.

A Cochrane systematic review is a rigorously conducted, independent review of research evidence on the effects of healthcare interventions, published by Cochrane, a global, not-for-profit organisation.

The latest randomised controlled trial, led by Professor Dumville will have further important implications for care and is likely to be published later in 2025 or early 2026.

Professor Dumville said: 鈥業 am delighted that our NIHR-funded research has delivered high-quality and relevant evidence on compression therapy for venous leg ulcers.

鈥淭he contribution of these findings to NICE鈥檚 late-stage assessment underscores the importance of NIHR studies like VenUS 6 in strengthening the clinical evidence base in wound care and informing national recommendations that support best practice in patient care.鈥�

Professor Cullum said: 鈥淭his is the first time there has been a piece of NICE guidance on compression therapy for venous leg ulcers.

鈥淚t feels like something of a culmination of all the work Jo Dumville and I have been doing for decades, so we are delighted it has culminated in some national guidance which will help nurses and patients arrive at informed decisions.鈥�

• See Professor Cullum鈥檚 Lockdown Lecture  where she talks about her work on leg ulcers and her with Jude Johnson.

Published in the American Association of Cancer Research (AACR) journal Cancer Research Communications, the study assessed AOA鈥檚 novel technology that analysed multiple groups of biological markers from a single blood sample. 

The researchers showed the test outperformed traditional biomarker tests for ovarian cancer detection in over 950 patients from Colorado and 野狼社区. 

This study is a major milestone and AOA is committed to pursuing regulatory approval across the US and Europe in the coming years, ahead of launching the test to the NHS. 

The technology combines two different sets of blood-markers, proteins and lipids, with   machine learning to identify the presence of ovarian cancer in women that present with vague abdominal/pelvic symptoms. 

In samples from University of Colorado the test exhibited an accuracy of 93% across all stages of ovarian cancer and 91% for early-stage disease. 

In a set from 野狼社区, the model continued to perform strongly, with an accuracy of 92% for all-stages of ovarian cancer and 88% for early-stage disease.

 AOA鈥檚 test performed better than single blood-based-markers which have been used for the past 30 year, which were only able to attain accuracies of less than 90%. 

The successful results, say AOA, will inform the final design of the test, which could produce a streamlined and cost-effective diagnostic relevant to healthcare systems globally. 

鈥淥ur platform detects ovarian cancer at early stages and with greater accuracy than current tools,鈥� said Alex Fisher COO and Co-Founder of AOA Dx. 鈥淭hese findings show its potential to aid clinicians in making faster, more informed decisions for women who need urgent clarity during a challenging diagnostic process.鈥� 

鈥淏y using machine learning to combine multiple biomarker types, we鈥檝e developed a diagnostic tool that detects ovarian cancer across the molecular complexity of the disease in sub-types and stages鈥� said Dr. Abigail McElhinny, Chief Science Officer of AOA Dx. 鈥淭his platform offers a great opportunity to improve the early diagnosis of ovarian cancer potentially resulting in better patient outcomes and lower costs to the healthcare system.鈥�

varian cancer is the fifth leading cause of cancer-related deaths among women, largely due to late-stage diagnosis.

Over 90% of women experience symptoms in Stage I, yet only 20% of cases are diagnosed in Stage I or II, as symptoms like bloating, abdominal pain, and digestive issues often resemble benign conditions.

Existing diagnostic methods, which rely on invasive procedures or less reliable markers, frequently fail to identify early-stage disease.

An accurate early detection test available to women when they first visit a physician with symptoms could revolutionize the detection of ovarian cancer.

Professor Emma Crosbie, Professor at The University of 野狼社区 and Honorary Consultant in Gynecological Oncology, 野狼社区 University NHS Foundation Trust (MFT), said: 鈥淎OA Dx鈥檚 platform shows significant promise for ovarian cancer early detection, offering a practical solution for symptomatic women.鈥�

Professor Crosbie is also National Institute for Health and Care Research (NIHR) 野狼社区 Biomedical Research Centre (BRC) Cancer Prevention and Early Detection Co-Theme Lead.

She added: 鈥淎OA Dx鈥檚 platform has the potential to significantly improve patient care and outcomes for women diagnosed with ovarian cancer. We are eager to continue advancing this important research through additional prospective trials to further validate and expand our understanding of how this could be integrated into existing healthcare systems.鈥�

The paper Utilizing serum-derived lipidomics with protein biomarkers and machine learning for early detection of ovarian cancer in the symptomatic population published in cancer Research Communications is available DOI:

The University of 野狼社区 is globally renowned for its pioneering research, outstanding teaching and learning, and commitment to social responsibility. We are a truly international university 鈥� ranking in the top 50 in a range of global rankings 鈥� with a diverse community of more than 44,000 students, 12,000 staff and 550,000 alumni from 190 countries.  Sign up for our e-news to hear first-hand about our international partnerships and activities across the globe. 

Published today  in the journal , the study provides a major insight into the muscular dystrophy subtype known collectively as Collagen VI-related dystrophy 鈥� or COL6-RD for short.

The team are the first ever to determine the high resolution structure of collagen VI- one of the networks of protein molecules that give our tissues mechanical strength and the ability to stretch and bend.

Called the extracellular matrix, the protein network also enables cells to sense their environment and communicate with one another in response to mechanical forces.

COL6-RD, which includes Ullrich congenital muscular dystrophy (UCMD) and  Bethlem myopathy (BM), can cause a range of symptoms including muscle weakness, joint contractures, decreased muscle tone, and weak breathing muscles.

It is one of a number muscular dystrophy subtypes and others include the more prevalent Duchenne-  caused by mutation of another protein -   for which scientists are developing gene therapies.

However, so far equivalent therapies have not been developed for COL6-RD.

Collagens are the most abundant extracellular matrix proteins, and form long fibres many times smaller than a human hair, called microfibrils. 

Collagen VI forms one type of microfibril, taking on the appearance of a large bead-like structure, consisting of  three separate protein chains, that twist and fold together.

The research required the scientists to develop small fragments of collagen VI, which they called mini-collagens.

Mini-collagens will be useful tools for studying or even treating the diseases associated with collagen VI mutations.

Lead author of Biotechnology and Biological Sciences Research Council funded study Clair Baldock, Professor of  Biochemistry at the University of 野狼社区 said: 鈥淚t is extremely important to understand where mutations in the tiny protein chains called collagen VI that cause a subtype of muscular dystrophy are, to help in the design of future treatments.

鈥淯sing a technique called cryogenic-electron microscopy -  which can magnify collagen VI hundreds of thousands of times-   we were able to determine the organisation of parts of collagen VI and map the disease mutations.

鈥淭hat provides an opportunity for scientists to design drugs which specifically target the mutations by focusing only on what's broken.

She added: 鈥淲e are the first group to determine the high resolution structure of collagen VI; until now, no- one has been able to show the locations of these mutations on the collagen VI structure.

鈥淭his is an important step along the path of finding ways to treat these types of muscular dystrophy and will provide momentum  to accelerate scientific discovery in this area.

鈥淲e hope that our structure will provide vital information to help the scientific community develop treatments, such as gene therapy, for collagen VI-RD.

鈥淭his provides some hope to people with muscular dystrophy that one day treatments will be available to improve their quality of life and help them to stay active and independent.鈥�

• The paper Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations is . https://doi.org/10.1038/s41467-025-62923-3

 Published in the American Journal of Nephrology today (11/08/25), the researchers show that higher levels of  Kidney Injury Molecule-1(KIM-1), a special marker of kidney damage in the blood and urine, are associated with higher risks of mortality and kidney failure, never before have the two been measured together. 

The research follows hot on the heels of their published in the Journal of the American Society of Nephrology last month, which measured 21 markers in blood and urine that reflect key processes driving kidney disease, inflammation, and heart disease. 

From the JASN study , the team pinpointed three standout markers that can predict both how quickly kidney disease will progress and the risk of death. 

Unlike the generic tests used in routine kidney clinics, the markers shine a light on the biological changes, underpinning CKD, that truly drive the disease. By revealing the hidden drivers, the discovery opens the door to new treatments designed to target the disease at its roots. 

Lead author Dr Thomas McDonnell, is both a researcher at The University of 野狼社区 and a kidney doctor at Salford Royal Hospital, part of Northern Care Alliance NHS Foundation Trust. 

He said: 鈥淭he progression of chronic kidney disease is highly variable between people,  so it鈥檚 difficult to predict which patients will progress to kidney failure or worse. 

鈥淏耻迟 our work raises the prospect of the development of  simple blood or urine tests that could better predict the degree of risk-  invaluable information for doctors and patients. 

鈥淲e think that , these models, which are more closely aligned with the underlying biological changes happening in chronic kidney disease, could allow a more tailored approach to the individual needs of patients.鈥�

The researchers analysed the blood and urine of adults with non-dialysis chronic kidney disease from 16 nephrology centres across the UK.

They analysed blood and urine KIM-1 in 2581 patients for the KIM-1 study and looked at all 21 markers of kidney damage, fibrosis, inflammation, and cardiovascular disease together in 2,884 patients for the second

They used statistical analysis  to assess how or if biological signals associated with kidney failure and mortality, and developed risk prediction models.

Because chronic kidney disease can stay stable for years in one person but suddenly worsen in another, doctors find it difficult to identify which patients are most at risk.

Existing blood tests currently only give doctors a partial picture, missing important clues like  inflammation and scar build up. As a result, people with the same CKD stage are often labelled has having the same risk and are given the same treatments.

Dr McDonnell added: 鈥淭his  discovery may will help doctors identify high-risk patients, so they enact more aggressive interventions, earlier specialist referral, and earlier treatment therapies.

鈥淎nd by identifying low risk patients, they  would be able to prevent over-treatment.

鈥淟iving with chronic kidney disease often means managing fatigue, having limits to what you can and can鈥檛 eat, and being consigned to  frequent medical appointments.

鈥淚t can be physically and emotionally challenging, but with the appropriate care, it is possible maintain an active and fulfilling life.鈥�

Plasma and Urinary KIM-1 in Chronic Kidney Disease: Prognostic Value, Associations with Albuminuria, and Implications for Kidney Failure and Mortality is published in   doi 10.1159/000547867is 

Biomarkers of kidney failure and all-cause mortality in chronic kidney disease  is published in the  DOI:10.1681/ASN.0000000767

Approximately one in 50 people will develop wounds that fail to heal with the issue a particular problem for older people and in diabetes. 

Chronic wounds are more likely to become infected and can even result in a need for amputation making tackling them a really important issue. 

The paper published in the , reveals that the enzyme-  called arginase 1 -  can  promote wound repair in the  skin, through modulation of  a protein called Lipocalin2. 

A major factor in non-healing wounds is a failure of the damaged outer layer of skin, the epidermis, to repair and regrow. This can be worsened by uncontrolled inflammation and infection. 

The authors show that on wounding Arginase 1 enhanced production of Lipocalin2, an anti-microbial agent, which was required to combat infection and help the skin cells reform the skin barrier. 

Arginase 1 also reduced levels of inflammatory products made by the damaged skin cells showing its potential for tackling the inflammation typically associated with chronic wounds.

 The researchers also showed that the function of arginase, could be restored to help skin regrow by adding products that arginase 1 can make which include metabolites called polyamines. 

The paper follows on from previous by the team, published in February, which showed how important this enzyme Arginase 1 was for healthy skin and eczema. 

A healthy skin barrier involves a balance between cells multiplying (鈥榩roliferating鈥�) and changing their function (鈥榙ifferentiating鈥�). A key feature of eczema is a disruption of this balance. Arginase is required for skin barrier regulation where it functions to promote cell differentiation, a process essential to maintain a protective healthy skin barrier. A process that is disrupted in eczema.

 Arginase 1 has been shown to have an important role in tissue repair but how it promotes skin health was until now, unknown. 

Lead author Sheena Cruickshank, Professor of immunology at The University of 野狼社区 鈥榮 Lydia Becker Institute of Immunology and Inflammation, said: 鈥淭hese two studies highlight the mechanism by which arginase 1 promotes barrier function and ensures good wound healing. 

鈥淚t鈥檚 importance is highlighted by the abnormal levels of Arginase seen in wounds that don鈥檛 heal well and eczema 

鈥淭hat is why we think that targeting arginase 1 has potential to be used in the treatment of eczema and non-healing skin ulcers. Data in the two papers suggest it might also protect the skin from infection.鈥� 

She added: 鈥淣on-healing skin wounds, or ulcers, are incredibly common and serious skin conditions that are more common as we age. 

鈥淭hey can have a devastating effect on the lives of patients, causing chronic pain, problems with mobility and can lead to increased morbidity. 

鈥淪imilarly, eczema can significantly impact quality of life, leading to intense itching, pain, and sleep disruption. It can also increase the risk of skin infections. 

鈥淲e clearly have a long way to go before these skin conditions can be cured, but knowing the crucial role of arginase 1 in the healing process and that we can rescue function in model systems is an important milestone.鈥� 

Jason Wong, Professor of Reconstructive Plastic Surgery and Regenerative Medicine  from The University of 野狼社区 said: 鈥淭he burden of chronic wounds seems to be on the increase and any new insights to how we can treat the problem will save limbs.鈥� 

The PhD studentship for coauthor Denis Szondi was funded by the Agency for Science, Technology and Research (A*STAR) Singapore and The University of 野狼社区. 

The Biotechnology and Biological Sciences Research Council (BBSRC) funded a PhD studentship for co-author Rachel Crompton. 

Banked tissue collection was funded by Wellcome Institutional Strategic Support Fund and supported by the National Institute for Health and Care Research (NIHR)野狼社区 Biomedical Research Centre (BRC). (Prof Wong is part of the Dermatology Theme at the NIHR 野狼社区 BRC.

British Journal of Dermatology, Volume 193, Issue 1, July 2025, Pages 125鈥�135, 

On Thursday 17^th July 2025, researchers from The University of 野狼社区 furthered their entrepreneurial journey by completing the MEC R2I programme at the Options Roundabout event. The event saw participants pitch their innovations to a panel of commercialisation experts, entrepreneurs and funders from across the University. The day concluded with a celebration of the cohort鈥檚 accomplishments with peers and supporters of the programme, as well as a networking opportunity to aid them in their next steps.

The R2I programme aims to inspire and accelerate the translation of academic research into impact-driven ventures. Over the course of 12-weeks, participants benefited from a series of bespoke workshops and mentoring opportunities to help them articulate their ideas and explore the commercial potential of their research.

Six Innovation Enabling Awards were granted to acknowledge the progress and growth potential, with early career researchers receiving between 拢2,000 to 拢10,000 to support the further development of their businesses.

Aurore Hochard, Director of the Masood Entrepreneurship Centre, presented the Innovation Enabling Awards to the six winning projects.

Award Winners

Innovation Enabling Award: 拢10,000

Lut猫o Medical

Dr Abigail Elias (School of Biological Sciences)

鈥�The support, mentoring, and resources provided through the Researcher to Innovator (R2I) programme have been transformative. Most importantly, the experience gave me the confidence to reach out to potential stakeholders and begin building the connections needed to bring my ideas to life. It was also great to connect with people on the cohort from such a broad range of disciplines."

Innovation Enabling Award: 拢5,000

ViRTUE: Virtual Reality Training in Ultrasonic Evaluation

Daniel Conniffe (School of Engineering)

鈥淩2I equipped me with the resources, motivation, and communication skills to bridge the gap between research and industry. Through building a strong network, I gained insight into real-world challenges and was able to pivot my research toward creating a meaningful, practical solution.鈥�

Innovation Enabling Award: 拢3,000

Hollowgraf

Dr Premlal Balakrishna Pillai (School of Engineering)

鈥淭he encouragement, guidance, and practical knowledge I gained through R2I have been truly inspiring. The programme really helped me to clarify my idea and shape it into a commercially viable opportunity, giving me the confidence to take the first steps into entrepreneurship.鈥�

Innovation Enabling Award: 拢2,000

PRECIOUS: Programmable Recovery of Critical Elements Using Synthetic Biology

Dr Sergio Guti茅rrez Zapata (School of Natural Sciences)

鈥淭he R2I programme gave me the push I didn鈥檛 know I needed. It helped me go from a scientific idea to something that could actually work in the real world 鈥� with real people and real challenges. Being able to shape a venture around bioremediation, and test the idea from different angles, has been incredibly motivating.鈥�

Innovation Enabling Award: 拢2,000

PRISM: Prostate cancer Risk Identification by Spectroscopic Measurement

Dr Dougal Ferguson (School of Engineering)

鈥�The R2I programme really helped me hone my ability to concisely and impactfully pitch my research as a commercial application. I am much more confident now pitching my science to a non-scientific audience!鈥�

Innovation Enabling Award: 拢2,000

Inclusive Skincare Solutions

Yoana Kirilova (School of Biological Sciences)

鈥淭he Researcher to Innovator programme has been a fantastic journey 鈥� connecting with like-minded peers, learning from experienced entrepreneurs, and gaining insights that will continue to shape my innovation journey.鈥�

The prize winners will also receive expert support and signposting to regional and national accelerator programmes and all the participants on the MEC R2I programme will be connected to the wider ecosystem for further support, mentoring and guidance in taking their research ideas forward.

The organisers wish to thank the Innovation Academy and the Engineers for Business Fellowship for their sponsorship of the Innovation Enabling Awards.

The  is supported by the University鈥檚 Innovation Academy. The Innovation Academy is a pan University initiative and joint venture between the , the  and the Business Engagement and Knowledge Exchange team, bringing together knowledge, expertise and routes to facilitate the commercialisation of research.

The research study was funded by the National Institute for Health and Care Research (NIHR), LifeArc and the Wellcome Trust and published in The Lancet Neurology today (16/07/25). 

Twenty-five years ago when Timothy Bingham was two years old, he had a mild flu like illness which left him unable to walk. 

Three years later following another infection, he was paralysed and has been in a wheelchair ever since. 

Then in 2011, doctors saw an 8-month-old girl at a UK hospital who had been completely fit and well until a mild chest infection left her unable to breathe without the support of a ventilator. 

They considered that there may be a genetic cause as her two brothers had experienced similar severe problems following mild infections. 

Genetic researchers at the University of 野狼社区 have now discovered that changes in a gene called RCC1 led to this severe nerve damage in both Timothy and the family in 野狼社区. 

A further 20 children from 10 families from the UK, T眉rkiye, Czechia, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia have been found to have changes in the same gene leading to this severe nerve condition all triggered by mild infections. 

In over half of the children, doctors suspected the diagnosis of a different severe nerve condition that can develop after infection called . 

The researchers performed laboratory studies on skin cells taken from patients and in specially genetically  engineered fruit flies to show that the damage to nerves can be caused by certain chemicals. 

Skin cells from patients when looked at under special microscopes have changes very similar to those seen in the cells of patients with motor neuron disease where muscles, including those controlling breathing and swallowing, become weak. 

Bill Newman, Professor of Translational Genomic Medicine at the University of 野狼社区 and Rare Condition co-theme lead at the NIHR 野狼社区 Biomedical Research Centre led the research. 

He said: 鈥淯ntil this study, little was known about why some people experience severe nerve damage after they have had a mild infection like flu or a stomach upset. 

鈥淭his work provides families with an explanation and is the first step in us developing an effective treatment. As children are well before they develop nerve damage following an infection, this gives us an opportunity to treat at risk children before problems occur. 

鈥淭he similarity with Guillain-Barr茅 syndrome and with conditions like motor neuron disease may help us understand these more common conditions and why some people are at greater risk and what treatments may be effective.鈥� 

Kate Bingham, mum of Tim who is now 28, said: 鈥淎bout 25 years ago Tim got a flu like infection and a temperature. What seemed like a minor illness had devastating consequences. 

鈥淭he attack, and subsequent attacks - did terrible damage. First to his legs, then his arms, his face and his chest. 

鈥淎nd now he needs 24-hour care. His diaphragm barely works at all so he can鈥檛 cough. It鈥檚 hard for him to chew and he can鈥檛 drink unassisted. He can鈥檛 move in bed so needs turning throughout the night. The things we all take for granted he can鈥檛 do. 

鈥淏耻迟 I鈥檓 proud of how strong Tim has been. He now has a girlfriend he met online who is wonderful. He proves there is life beyond disability.鈥� 

She added: 鈥淎s Tim鈥檚 mum the discovery of a gene which is linked to what happened to Tim means everything to me. For so long we have lived with uncertainty of not knowing the full picture. 

鈥淭his breakthrough brings us great hope as it will do to all those people who have waited years for answers. This is something that helps us look to the future.鈥� 

Sam Barrell, CEO of LifeArc, said, 鈥溾�淔or many people living with rare conditions, the wait for a diagnosis can be agonisingly long - around a third wait more than five years. In Timothy鈥檚 case, that uncertainty stretched for over twenty years.  This discovery provides a potential target for treatment and the first step towards delivering a brighter future for people that could be living with this same devastating condition.鈥� 

Image: Kate and Tim and Tim with his dog, Red.

The paper Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series is published in The Lancet Neurology here DOI 

Up to 拢50 million is to be invested in a Medical Research Council Centre of Research Excellence (MRC CoRE) in Exposome Immunology over the next 14 years.

These environmental exposures, which also include things like microbes and toxins, predominantly interact with our bodies at what we call 鈥榤ucosal barrier sites鈥�, for example our lungs and intestines. Here, they met by our immune cells, and can change how the immune system works, pushing some tissues into chronic inflammation, causing diseases such as asthma, chronic obstructive pulmonary disorder (COPD) and inflammatory bowel disease (IBD).

The centre will embrace AI technology to interrogate large data sets, such as those from UK Biobank, patient cohorts and long-term studies in hospital clinics, and identify common pathways by which environmental factors disrupt the immune system. Findings will be tested through laboratory studies and by exposing healthy volunteers to pollutants and common viral infections, leading to more accurate diagnoses, better prevention, and more effective treatment options.

Individuals from disadvantaged socioeconomic backgrounds often have a more adverse exposome, facing greater exposure to pollution, mould (in poor quality housing), and occupational hazards (cleaning chemicals, industrial processes). The MRC CoRE is therefore key to The University of 野狼社区鈥檚 mission to address , and builds on work investigating .

Professor Judi Allen, from The University of 野狼社区 is Director of the MRC CoRE in Exposome Immunology.

She said: 鈥淕lobally we鈥檙e facing a crisis in chronic inflammatory diseases, such as asthma and inflammatory bowel disease. For decades we鈥檝e been studying how our genes make us susceptible to disease. While very valuable, genetics has only got us so far. We need to understand how our environment interacts with our genes to make our immune system malfunction.鈥�

鈥淲e will benefit from advances in new technologies to identify which of the many complex factors may be important in driving disease, but what鈥檚 different about our new Centre is we are going to define how the immune system is altered by these environmental factors and how that impacts inflammation. Changing environments, often made worse by socioeconomic disparities and rising pollution, appear to be increasing the rates of these diseases, making it even more imperative to find the causes.鈥�

鈥淲e hope to later expand our research to include more environmental factors, such as mould and microplastics, which are growing concerns. An ultimate goal of this research would be to discover the underlying causes of these chronic diseases so we can develop better prevention and treatments.鈥�

Professor Fiona Powrie, co-director of the MRC CoRE in Exposome Immunology, from University of Oxford, said: 鈥淭his is an exciting opportunity to bring together complementary expertise in The University of 野狼社区 and University of Oxford to build a multidisciplinary team to tackle this challenge. Our Centre will train a new generation of scientists working across biology and environmental science, future proofing our efforts to combat the health effects of a changing environment.鈥�

Professor Patrick Chinnery, MRC Executive Chair, said: 鈥淭his new MRC Centre of Research Excellence will transform our understanding of how lifelong environmental exposures shape immune health and cause chronic inflammatory diseases. With chronic inflammatory diseases posing such a large and growing disease burden, the new centre is well placed pave the way for more effective and targeted treatments.

鈥淎longside exceptional scientific leadership linking two world-leading centres, and strong partnerships with patients and digital health innovators, the scientists鈥� commitment to the next generation of researchers will embed UK leadership in this field, with long-term potential to deliver a transformative, global impact for health.鈥�

The findings - based on the scans of 1,684 women - could make the difficult task of determining whether labour should be induced in the final stages of pregnancy easier, resulting in fewer complications, say the researchers.

Published today in the Lancet Obstetrics, Gynaecology and Women鈥檚 Health, the study was led by gynaecologist Sanne Gordijn of the University Medical Center Groningen (UMCG) in collaboration with Wessel Ganzevoort of Amsterdam University Medical Centre and Professor Alexander Heazell from The University of 野狼社区.

When pregnant women feel their baby is moving less in the final weeks of pregnancy, they are referred to hospital where an examination is carried out to assess the condition of the baby.

The examination consists of monitoring the baby鈥檚 heart rate and an assessment of its growth and amniotic fluid - the fluid around the baby it.

Now the researchers have discovered that an extra ultrasound scan - in addition to the other tests-  is able to significantly help doctors to see whether a baby would benefit from being born earlier.

By measuring the resistance in the blood vessels of the umbilical cord and the baby's brain they were able to accurately assess the functioning of the placenta and the condition of the baby, making it easier to decide if doctors needed to induce delivery earlier.

The perception from mothers that their baby is moving less commonly can occur when a baby has changed position or the mother hasn鈥檛 noticed the movement because she is busy or distracted.

However in some cases, reduced movement could be a sign that the baby is unwell, which can be worrying for pregnant women and midwives.

Professor Heazell said: 鈥淲e know that a reduction in baby鈥檚 movements is a common reason to attend maternity services. Thankfully, in the majority of cases the baby is ok.

鈥淭he findings of this study will help us to reassure the majority of mothers that their baby is healthy, and help us to focus intervention for the babies who will benefit from being born because they are not receiving enough oxygen or nutrients in the womb.鈥�

Sanne Gordijn said: 鈥淲e call the ratio between the two ultrasound measurements the Cerebro Placental Ratio (CPR). The idea is that an abnormal value may indicate that the placenta is not functioning properly.

鈥淚n that case, it is better for the baby to be born in the short term. We do this by inducing labour. If the value is normal, it would be better to wait for the natural moment of delivery, as the baby may not be completely ready yet. Women who want to give birth at home can still do so.鈥�

鈥淭he results of this study show better outcomes for the baby when the result of the CPR measurement is known.

鈥淭his means that we see fewer complications during childbirth when this measurement is taken, compared to the current policy where it is not done.鈥�

She added: 鈥淚f doctors know the results of this measurement, they can better distinguish whether the baby's reduced movement has a harmless cause or whether it requires action.

鈥淭his ensures that mother and baby receive the care that best suits their situation.' The guideline on reduced fetal movements will soon be updated; the professional association will incorporate the results of this study into it.鈥�

The study was funded by ZonMw from the Netherlands.

Sanne Gordijn conducted this CEPRA study together with researchers from Amsterdam UMC in 23 hospitals. Laura Lens, the MD, PhD student on this study presented at the international SMFM conference in Denver (USA) and Sanne in London. The study is published on July 10 in the authoritative scientific journal The Lancet Obstetrics, Gynaecology & Women鈥檚 Health.

• The study is published in the Lancet Obstetrics, Gynaecology and Women鈥檚 Health and is available
• doi.org/10.1016/j.lanogw.2025.100002

Despite tearing his right knee ligament just eight weeks ago, the customer service officer 鈥� who works at a Halifax Housing Association 鈥� will walk 120 miles nonstop, without sleep.

Starting at the Angel of the North in Gateshead on Saturday 12 July, 42-year-old Ben will make his way to Tommy鈥檚 Rainbow Clinic and Maternal and Fetal Health Research Centre at Saint Mary鈥檚 Hospital 鈥� the specialist unit that helped save his son鈥檚 life.

Just seven days later, after flying to Rhodes, Ben will climb the steep mountain road to Prophet Elias Monastery in Faliraki, Greece an exhausting 50 times 鈥� a gruelling test of endurance with no shade and where temperatures are likely to soar above 40掳C.

Ben is aiming to raise 拢20,000 for Professor Alex Heazell, Director of the Tommy鈥檚 Stillbirth Research Centre and the University of 野狼社区-based team leading UK research to reduce preventable stillbirths and support families through pregnancy after loss.

Ben and his partner Gaynor Thompson lost their daughter Kallipateira to a preventable stillbirth at 37 weeks in October 2018. They later suffered a miscarriage in 2019.

Determined to stop other families going through the same heartbreak, they founded The Kallipateira Moorhouse Foundation, which funds research and supports families affected by baby loss.

In 2020, their son Apollon was born safely at Tommy鈥檚 Rainbow Clinic, thanks to the specialist care of Professor Heazell.

Ben has since taken on multiple extreme solo fundraising feats.

鈥淭his year has brought mountains I鈥檝e had to climb emotionally and physically. Now, I鈥檓 preparing to put myself through the mill 鈥� fuelled by love, grief, and purpose,鈥� said Ben.

鈥淭here鈥檚 no pain greater than holding your dead baby in your arms 鈥� but every step I take will honour Kallipateira and help save other babies across the UK. I will once again show that because of love and a reason why, anything is possible.鈥�

Every day in the UK, eight babies are stillborn 鈥� many of which are preventable.

The funds Ben raises will go directly to Professor Heazell鈥檚 team, who are making groundbreaking progress in understanding stillbirth and supporting parents in pregnancy after loss.

Alex Heazell, who is also Professor of Obstetrics at The University of 野狼社区 and Honorary Consultant Obstetrician at Saint Mary鈥檚 Hospital, part of MFT, said: 鈥淏en鈥檚 unwavering commitment is extraordinary. His support has already helped us improve care for families and expand our research into stillbirth prevention. These challenges will fund new projects that could save lives.鈥�

Dignity Funerals, through Lawrence Funeral Directors Halifax, are proud headline sponsors of Ben鈥檚 2025 challenge.

Stuart Cox, Head of Public Affairs at Dignity, said: 鈥淏en is a true inspiration. We鈥檙e honoured to support The Kallipateira Moorhouse Foundation and the vital work they do in memory of Kallipateira.鈥�

To support Ben鈥檚 Mission donate now at: 

The University of 野狼社区 project has been awarded the grant through the NHS Cancer Programme Innovation Open Call with support from SBRI Healthcare (Small Business Research Initiative) as part of a new, unique national partnership which could save lives and improve quality of life.

Researchers in 野狼社区 will implement an innovative lung cancer risk assessment tool and an adapted care pathway for Hodgkin lymphoma survivors, supported by the National Institute for Health and Care Research (NIHR) 野狼社区 Biomedical Research Centre (BRC).

The new multi-centre study started in June 2025 and will be running for two years within the existing NHS Lung Cancer Screening Programme at 10 Cancer Alliances across England, including Greater 野狼社区 Cancer Alliance leading the initiative.

Every year, around 2,100 people in the UK are diagnosed with Hodgkin lymphoma, a cancer that develops in the lymphatic system (part of the immune system).

Although it is a highly curable cancer, treatments such as chemotherapy and radiotherapy to the chest and lungs increase the risk of second cancers occurring in later life. This risk increases further for people who smoke.

Survivors of Hodgkin lymphoma are six times more likely to develop lung cancer than the general population.

Study lead Dr Kim Linton, Senior Lecturer at The University of 野狼社区 and Living With and Beyond Cancer Co-Theme Lead at 野狼社区 BRC, said: 鈥淚t is crucial that Hodgkin lymphoma survivors can access screening to detect lung cancer at an early stage, when it is more treatable.鈥�

Developed in 野狼社区, the new UK-wide programme aims to screen 500 Hodgkin lymphoma survivors over two years, which could detect early lung cancer in an estimated 10-12 people.

Joanne Murray, from Didsbury in 野狼社区, was diagnosed with Hodgkin lymphoma in 1997 at the age of 29 and received successful treatment at The Christie NHS Foundation Trust.

She took part in the pilot study in 2022 which helped 野狼社区 researchers design the new national programme. Despite having no symptoms, the study found Joanne had stage 1 lung cancer.

Now 56 and living in North Wales, Joanne said: 鈥淚 feel exceptionally lucky that this research has saved my life. I had no symptoms of lung cancer and had I not taken part in this study, it might have been too late for me once symptoms had appeared.鈥�

Through the study, Joanne had a CT scan at The Christie in 野狼社区 which revealed a 鈥榝luffy鈥� and opaque nodule (small lump) on her right lung. Following surgery to remove part of her lung, a biopsy revealed it was stage 1 cancer.

Joanne, who works for North Wales Police, explained: 鈥淎fter my scan, doctors closely monitored me through 鈥榳atch and wait鈥�, with regular check-ups to determine if the nodule grew or if I developed symptoms. In November 2023, after I had moved to Wales, a follow-up scan at my local hospital showed that the nodule had grown by 1mm. After discussing my treatment options, I decided to have surgery to remove part of my right lung.鈥�

Joanne had the surgery in January 2024 at Liverpool Heart and Chest Hospital. She said: 鈥淚 was absolutely terrified of having the surgery, but it was fine, and all the staff were fantastic. I had video-assisted thoracoscopic surgery [a form of keyhole surgery] which was less invasive, and I was back home in two days to recover.

鈥淲hen I found out from the biopsy that it had been stage 1 cancer, I was in complete shock. I鈥檓 a positive person and thought I had just been overthinking it. I am so thankful for this vital research and the team at The Christie.鈥�

Now 18 months later, Joanne has had two clear scans, with the next one due in early 2026.

On taking part in research, Joanne said: 鈥淲hen I read the letter asking me if I wanted to be part of research I thought, 鈥榯here鈥檚 nothing wrong with me, but I鈥檒l do it.鈥� You never know what鈥檚 around the corner.

鈥淲ithout doubt, I would urge other cancer survivors to take part in screening. It might take 10 or 15 minutes out of your day, but it could save your life.鈥�

Hodgkin lymphoma can develop at any age, but it mostly affects people between 20 and 40 years of age and those over 75. The most common symptom is a painless swelling in a lymph node, usually in the neck, armpit or groin.

Second cancers, such as lung cancer or breast cancer, can develop more than 10 years after treatment for Hodgkin lymphoma. Survivors can help to reduce their risk of a second cancer by adopting a healthy lifestyle through not smoking, maintaining a healthy weight with a balanced diet, and getting regular exercise.

Dr Linton, who is also an Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust, said: 鈥淢ost Hodgkin lymphoma survivors do not meet current lung cancer screening criteria, so we hope the success of this study will support an application for routine adoption across England and Wales.

鈥淚n 野狼社区, we have been working on a lung cancer screening programme for Hodgkin lymphoma survivors for many years, including a pilot screening study at The Christie where we detected 3 lung cancers in 102 people who had showed no symptoms.

鈥淭his research helped us to design the national programme and confirmed that our proposed study meets the needs of this high-risk patient group. This work also builds on 野狼社区鈥檚 previous track record of successfully implementing breast cancer screening for Hodgkin lymphoma survivors within the national breast cancer screening programme.鈥�

The new study will be open to Hodgkin lymphoma survivors aged between 45 and 74 who smoke or have previously smoked.

It will have an embedded programme to identify and tackle health inequalities, including people where their risk of lung cancer is highest, such as those with lower socioeconomic status, men and older people.

It will help address barriers to screening participation, such as fear of cancer diagnosis, low perceived risk of cancer and issues of cost, travel and time off work.

Screening will take place at convenient community-based settings to encourage participation, including in mobile clinics at supermarket car parks.

Researchers will actively promote screening participation for people with the highest smoking prevalence.

Participants will be offered health education and stop smoking advice to encourage supported self-management to prevent lung cancer, cardiovascular disease and other significant illnesses, which could lead to improved survivorship and reduced healthcare costs.

The 野狼社区-based project is part of the NIHR 野狼社区 BRC鈥檚 , which aims to transform the detection of cancer recurrence and second cancers to improve quality of life and treatment outcomes for survivors.

Researchers will also be collaborating with the NIHR 野狼社区 BRC鈥檚 , which aims to reduce cancer burden across society through implementing prevention and early detection strategies.

The project will be supported by the NIHR Oncology Translational Research Collaboration, Lymphoma Action charity and patient partners.

Health Innovation 野狼社区 will work with Greater 野狼社区 Cancer Alliance to support local adoption and run patient focus groups to understand barriers to engagement and develop solutions to improve uptake.

• images: Dr Kim Linton and  Joanne and Rob

The former GP, Director of Public Health and Medical Director was tragically killed in a terrorist attack while holidaying in Sri Lanka. 

She studied medicine at The University of 野狼社区 and started her medical career as a GP in Salford. 

Her brother Lord Keith Bradley will today (9/07/25) present this year鈥檚 prize to Mark Westwood, who received a distinction at the 13th International of Public Health. 

Mark, who has worked in the NHS and volunteered with the Scouting movement is hoping to join the University as a PhD student. 

Lord Keith Bradly 鈥� a Labour Party politician created the award in his sister鈥檚 name to recognise highest achieving Masters in Public Health (MPH) student from Greater 野狼社区. 

Prof Arpana Verma, Programme Director of the MPH said: 鈥淪ally was an inspiration to us all. Not only was she a remarkable clinician and public health doctor, she was a wife, sister, aunt, friend and colleague to countless many. 

鈥淪he was kind, clever and incredibly knowledgeable. She lit up the room with her charisma, charm and her infectious laugh. 

鈥淭here are no words to express our gratitude to Lord Bradley and Sally鈥檚 amazing family to honour our programme and our students with this inspirational award.鈥� 

She added: 鈥淎s we teach and train the next generation, we can give our students and alumni the incredible legacy Sally has left us. 

鈥淢ark is a worthy recipient of this honour. He has been an exceptional student and will go on to make important contributions to the field of public health. 

鈥淗is voluntary work has been exceptional -  and signifies just how much he cares about the community in which he lives 

The Masters in Public health online programme, created in 2002 by Prof Dick Heller, was was one of first fully distance learning programmes in the UK. 

Since then it has grown to over 2,000 alumni from all over the world, offering fully flexible learning options to allow students to juggle working full time with their studies.

Lord Bradley said: 鈥淥n behalf of my family, I am proud to pay tribute to my sister, Dr Sally Bradley, who was so cruelly killed alongside her husband Bill in the Easter Day bombings in Sri Lanka some 5 years ago. 

鈥淪ince that time, I have recovered numerous messages of kindness remembering Sally and conversations with many of her former colleagues and friends who stressed how inspirational she was to their careers and her utter commitment to preventative healthcare and the crucial role of public health in that endeavour. 

鈥淚 am delighted that Mark Westwood will receive this year鈥檚 Dr Sally Bradley prize. He clearly encapsulates the values that my sister tried to instil in public health in 野狼社区 and well beyond. He is a tremendously worthy winner. 

鈥淚 and my family are honoured to ensure that Sally鈥檚 legacy will live on and that we all continue to strive for improved health and wellbeing throughout our communities.鈥� 

Students can to learn the 鈥榓rt and the science鈥� of public health at their own pace, with a choice of over twenty different course units covering what professionals need for their careers in public health both here and internationally. 

The course concentrates on research-led teaching and students are encouraged to participate and learn from research partners and projects, especially for their dissertations. 

The themes of this year鈥檚 festival are AI and In-Silico Public Health, Women鈥檚 research and Inclusive Research. 

• More information on the Masters in public Health programme is available here
• Image is of Sally Bradley.

By carefully monitoring the level of cancer activity in the blood, doctors can identify the best time to start and stop the drugs to give treatment breaks, which it is hoped will prevent resistance to treatment developing and also reduce side effects. This experimental blood test could help people with stage 4 melanoma, a type of skin cancer, live longer. 

The ground-breaking approach looks for tiny fragments of DNA coming from the cancer, which can be found in the patient鈥檚 blood. 

Dr Rebecca Lee, consultant oncologist and clinician scientist at The Christie and a senior lecturer in Medical Oncology at The University of 野狼社区 is leading on the DyNAMIc trial.She said: 鈥淐ancer treated with targeted therapy can be thought of as two armies of cells; those that are sensitive to the treatment and those that are resistant, which fight for nutrients in order to grow. A patient does not want either cell army to win as that means their cancer will get worse. Although the targeted therapy can kill the sensitive cells, over time the resistant ones grow through. However, if treatment breaks are given, it is thought that the growth of these resistant cells can be suppressed by the sensitive cells. 

鈥淭his blood test enables us to develop a new approach to overcome resistance to targeted therapy treatment. The DyNAMIc trial is really at the forefront of precision medicine. We can adapt the treatment in response to the patient鈥檚 melanoma activity levels in real-time and therefore reduce the chance of the cancer becoming resistant in the long term.  This could be a real game-changer in how we treat melanoma and other patients with cancer undergoing similar treatments in the future.鈥� 

Professor Paul Lorigan, consultant oncologist at The Christie and chief investigator for the DyNAMIc trial said: 鈥淓valuating new biomarker in clinical trials such as DyNAMIc allows us to personalise treatment decisions and continue to improve outcomes for patients with melanoma and other cancers.  The close collaboration between The Christie and the National Biomarker Centre has allowed us to take this from concept to clinical trial.  The study is now open in ten centres in the UK, led by the 野狼社区 team. This would not be possible without support from the patients and their families, The Christie and The Christie Charity, Jon Moulton Charity Trust, Cancer Research UK and many other colleagues.鈥� 

Dr Dominic Rothwell, the Deputy Director of the Cancer Research UK National Biomarker Centre and one of the team who helped develop the test said: 鈥淭he DyNAMIc trial is a great example of how cutting-edge research, funded by the Jon Moulton Charity Trust and CRUK can lead to the development of exciting new tests and how, in close collaboration with our clinical colleagues, these tests can be transferred to the clinic and lead to the potential improvement of treatments for cancer patients.鈥� 

The first patient to join this clinical trial was a supermarket worker from Stockport in Greater 野狼社区. Jan Smith (64) had been working on the shop floor at her local superstore in November 2022 when she started to experience severe pain and was rushed to A&E. A scan revealed kidney stones which doctors were able to treat successfully.  However, the scan also showed a shadow near her left kidney which was far more serious. It was a 12-inch-deep mass around her adrenal gland at the top of her kidney and a biopsy confirmed she had stage 4 (the most advanced stage) melanoma in December 2022. 

The self-confessed 鈥榗razy cat lady鈥�, who shares her home with five much-loved moggies, was referred to The Christie. 

鈥淚 hadn鈥檛 had any symptoms and never take time off sick at work. The pain I had with the kidney stones was unbelievable. Like nothing I鈥檇 known before. But in a strange way they saved my life.鈥� Jan explained: 鈥淚t was good news to be told that they had managed to clear the stones but a real shock to discover I had cancer. My local hospital said they couldn鈥檛 remove the tumour as it was too big, so I was referred to The Christie for more specialist treatment.鈥� 

In January 2023 Jan began a course of immunotherapy, which uses the body鈥檚 own immune system to fight the cancer. Unfortunately, within weeks her condition worsened, and she developed speech difficulties and weakness on one side of her body. Jan was given the devastating news that she had developed two brain tumours and needed emergency life-saving surgery to remove part of the tumour in the right side of her head. 

Unfortunately a scan in October 2024 found a new growth near Jan鈥檚 liver so she was offered the chance to participate in research at the ) at in 野狼社区. Jan was told in the November she was eligible for DyNAMIc, a clinical trial which aims to improve how well the treatment works for patients whose melanoma can鈥檛 be removed by surgery or has spread. 

Jan was prescribed two targeted drugs, encorafenib and binimetinib which is an approved treatment in patients with melanoma. They suppress a protein called BRAF, which causes melanoma cells to survive and grow. Around half of people with melanoma have a BRAF mutation which can become overactive.  

These drugs stop the cancer growing and can shrink the tumour by killing off the cells with the abnormal gene. But the cancer can fight back and develop more changes and become resistant to the treatment. Therefore, a sensitive blood test which precisely measures the amount of circulating DNA from the cancer enabling treatment can be turned on and off as required could be very beneficial to patients. 

Talking about her experience of being on the clinical trial, Jan Smith said: 鈥淭his has been quite a journey with one thing after another, and my battle with cancer is certainly not over yet.  Despite numerous setbacks and changing treatments, I鈥檝e tried to always stay positive and I鈥檓 glad to be benefiting from this trial.

鈥淚 am pleased to take part in research. If we don鈥檛 try new treatments, then we鈥檒l not get the answers and make the medical advancements we need.鈥�

The DyNAMIc study is open for recruitment with the aim of recruiting 40 participants.  The trial is funded by the Jon Moulton Charity Trust, sponsored by The Christie and run by the Liverpool Clinical Trials Centre.  

According to Cancer Research UK, new treatments for melanoma have improved outcomes in recent years. Around half of people with stage 4 melanoma can now survive for 10 years or more.

Dr Rebecca Lee is a senior lecturer in Medical Oncology at The University of 野狼社区 and her post at The Christie is funded by .

Any patients interested in taking part in clinical trials should discuss this option with their consultant or GP. Not all patients will fit the criteria for a specific trial. While clinical trials can be successful for some patients, outcomes can vary from case to case. More information about taking part in clinical trials can be found .

To date, over 2000 patients have consented to be part of the ID LIVER study, with more than 600 assessed in community settings across Greater 野狼社区 over the last year, as part of the . 

This research project is delivered as part of a series of projects that looks to address Greater 野狼社区鈥檚 major diseases for the Advanced Diagnostics Accelerator (ADA), part of the . The Accelerator has been established to rapidly improve the diagnosis and treatment of disease across the 2.8m Greater 野狼社区 population.

Stephanie Landi, Clinical Research Hepatology Fellow at 野狼社区 University NHS Foundation Trust (MFT), said: 鈥淚D LIVER is shifting the focus of liver disease care towards early detection and intervention. By bringing liver health assessments directly into communities, we are removing barriers to access and reaching people who might otherwise present much later with advanced disease. We also know that liver disease disproportionally impacts those living in areas of high socioeconomic deprivation, so by targeting these communities, we are ensuring care reaches those who need it the most. Early detection empowers individuals to understand their liver health and make informed decisions before complications develop.鈥�


Health Innovation 野狼社区 met with Tony, aged 68 from Greater 野狼社区, who attended the Early Detection of Liver Disease (ID LIVER) health check in his locality, following a referral from his General Practitioner (GP). 

Tony decided to act on this referral after meeting the criteria for the screening opportunity and followed up before an appointment was made for him. He explained that he was pleasantly surprised that the health-check was so easily accessible for him:

鈥淎n appointment was made for me鈥� I turned up and it was all very pleasant, there was no stress, no worry 鈥� I just turned up, did the test which was a scan, and that was it. The opportunity is there and there are people out there who want to help you, it鈥檚 all being done to help you. It鈥檚 all about you, the patient.

鈥淭he thing for me, is that it鈥檚 done in my locality, it鈥檚 within walking distance鈥� the way this is being done, this is the beauty of it, you鈥檙e just there and it鈥檚 all about you. It鈥檚 intimate really and it makes life easier. If you take the opportunity to get screened and get looked at, you鈥檙e cutting out a load of possible aggravation in the future.鈥�

ID Liver participants are benefiting from state-of-the-art Greater 野狼社区 Research Van - operated by MFT. The purpose-built vehicle is unique to the region with the goal of widening opportunities for people to be part of research in easy-to-reach locations, improving the relevance and quality of the research. as well as being more inclusive for members of the public.

Oliver Street, Programme Manager, Division of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine and Health at The University of 野狼社区, said: 鈥淓arly detection and prevention of liver disease is extremely important because often symptoms do not present until the disease is advanced and damage to the liver is irreversible. By identifying and assessing patients at increased risk of liver disease we are supporting patients in receiving the right treatment at the right time and developing improved pathways of care.鈥�

Daniel Zamora, Programme Director 鈥� Health Innovation Accelerator at Health Innovation 野狼社区, said: 鈥淭his project is another fantastic example of how a targeted approach for early detection and community screening is having a lasting positive impact on the treatment of disease for people across Greater 野狼社区. Through the Accelerator we鈥檝e now seen a considerable number of patients tested and screened for some of our region鈥檚 most prevalent diseases. This work will continue to help us shape how we can identify and treat patients moving forward with the use of innovative solutions across primary, secondary and community care settings

In the first ever study of its kind, tennis fan Dr Liam Blything analysed the impact of timeouts using from the world鈥檚 top 250 players between 2013 and 2023. 

Players at this year鈥檚 Wimbledon Championships will be watching closely how their opponents take a bathroom break, in light of the study. 

The paper follows years of speculation by journalists and sports people that the practice amounts to gamesmanship, bestowing an advantage for players taking a bathroom break by disrupting the rhythm of their opponent. 

However, proponents of the bathroom break argue that timeouts are a useful and acceptable way to help players reset.

 In response, the Association of Tennis Professionals (ATP) introduced a rule for the 2022 season to restrict timeouts to a maximum of 3 minutes, alongside limitations on when and how often they can be deployed. 

Published in the peer reviewed International Journal of Performance Analysis in Sport, Dr Blything found that 71% of time outs were taken when a player lost the previous set. 

And in normal circumstances, 33% of players recover the next set after losing the previous one. This, however, rose to 47% if they took a bathroom break. 

The data analysed by Dr Blything showed there were 1,928 breaks in play in the study period, though when medical and other breaks were accounted for, he was left with 366 bathroom timeouts. 

Dr Blything said: 鈥淭here has been much argument in the media over recent years about the formalisation of gamesmanship in tennis, with the taking of bathroom breaks. 

鈥淭his study for the first time used real data to check the validity of those concerns. 

鈥淭here is now clear evidence a well-timed bathroom break in play confers an advantage to the player taking the break by regathering him or herself and disrupting the flow of the opponent..鈥� 

Dr Blything also carried out follow up analyses on the extent to which unforced-errors contributed to the forms of points won and lost. 

The overall decrease in the opponent鈥檚 winner-shots was offset by an equivalent decrease in the strategist鈥檚 unforced errors, preserving the proportion observed in the baseline data. 

That showed timeout advantage is a combination of both the strategist benefitting from the opportunity to personally reset, and a disruption of the rhythm of the opponent, rather than being disproportionally driven by one player. 

Psychological theory also supports the notion that taking a break can confer advantages by interrupting momentum. 

Theorists argue an interruption disrupts perceptions associated with positive momentum for players who are on a roll, which is in turn difficult to regain. 

The timeout also potentially affords the opportunity for a losing player to refocus from that negative thinking spiral about prospective outcomes, for example by using self-talk and mental imagery techniques. 

Dr Blything added: 鈥淭hese pioneering findings uniquely inform players and tennis governing bodies about the influence of timeouts and, more broadly, elucidate the role that stoppages can play in sport for altering momentum. 

鈥淚t would be useful understand if this effect is relevant  in other sports. Snooker players, for example, seem to take a lot of bathroom breaks.鈥� 

Examples of comments from players:

Andy Murray on a Stefanos Tsitsipas bathroom break after Murray won the 4th set 2-2 in the 2021 US Open 1st round. He went on to lose 3 - 2. 鈥淚t鈥檚 just disappointing because I feel it influenced the outcome of the match. I鈥檓 not saying I necessarily win that match, for sure, but it had influence on what was happening after those breaks.鈥�

Roger Federer who took a bathroom break after losing the 4th set 2-2 in the 2017 Australian Open semifinal. He went on to beat Wawrinka 3-2. 鈥淚 think they're more mental than anything else. I only really did take the timeout because I thought, 'He took one already, maybe I can take one for a change'. Because I'm not a believer in any way that we should be allowed to take a lot of timeouts. But I took it after the set break. People know I don't abuse the system. I hope it's going to stay that way in the future for me, too.鈥�

Stefanos Tsitispas, who鈥檚 opponent Novak Djokovic took a bathroom break after losing 2nd set to make it  0-2 in the 2021 French Open Final. Djokovic recovered to beat Tsitsipas 3-2: 鈥淚 don't think I changed much, I just kept the same pace. I kept the things that were working for me. He left the court after two sets to love down, and he came back to me like a different player suddenly. I don't know. I have no idea.鈥�

On the same match, Djokovic said: 鈥淭he bathroom break was the turning point. Sometimes in these kind of circumstances where not much is happening positively for you on the court in terms of tennis and the other guy on the court is dominating the play, sometimes these things are necessary. A little break, a little pep talk, and try to recuperate and re-gather the thoughts and reassemble everything that you have and [counter] your opponent with the best possible game.  Maybe it's the experience, maybe it's the toilet break, maybe it's everything combined, but I'm just glad I'm through.鈥�

The paper psychological (ab)use of timeouts in professional tennis is available DOI: 10.1080/24748668.2024.2436271:

This empowering accelerator, crafted specifically for students and recent graduates, brought together 22 exceptional student founders from every corner of the University of 野狼社区. The breadth of talent included Computer Science innovators working alongside Biotechnology pioneers, Economics strategists collaborating with Chemical Engineering problem-solvers, with representation from undergraduates right through to PhD candidates. 

The intensive 12-week programme, designed to take participants from initial concept to business execution, concluded with presentations from all participating student startups. The session featured valuable feedback and insights from industry professionals Ranvir Singh (GC Angels) and Dan Sandler (CEO of Veridox), who provided expert guidance to the emerging entrepreneurs. Ranvir also shared his thoughts on the importance of persistence, that "Excellence in any field demands unwavering commitment and effort".

Throughout the programme, participants validated business ideas, developed actionable business models, created minimum viable products, and mastered essential skills including market validation, fundraising strategies, and pitching techniques. All 22 student entrepreneurs successfully presented their ventures, representing diverse sectors and innovative solutions.

Congratulations to all our graduates and their innovative ventures: 

• AccuNote - Evangelos Anapliotis  
• Aharik - Maansi Gupta  
• ARDHANN - Dr Sangeethsivan Sivakumar  
• Aurora-Hive - Yasar W Khan  
• Binary Aura - Taha Naeem  
• Branchify - Chih Chiang yang  
• CoordVenture - Ehsan Siddiqui  
• FoulGuardAI - Abdullah Albiladi  
• FurryWell - Pu-De Ciou  
• Groupy - Jonghun Lee  
• Gynomics - Dora Mar膷ec  
• Neurotect - Dylan Simpson  
• PawFur - Donglin Zhao  
• PetFit - Rebecca Jibson  
• PulsR - Leo Feasby  
• PurFetch - Raymond Xiang Zheng  
• Quillall - Serban-Andrei Locota  
• Reviewer.Go - Altynai Mambetova  
• Sync It - Matilde Ferias  
• TerraIQ - Imaara Keshwani  
• UniSights - Sebastian Contreras Scheuermann  
• Vesta Capsules - Farah Frikha

The Venture Builder Programme has proved transformational for its founding cohort, providing essential frameworks for turning ambitious ideas into viable businesses.  

 "It has helped us validate our assumptions. Initially, we didn't know what would work and what wouldn't, what to scrap and what to keep. Venture Builder has helped us clarify our vision for our startup, so we can go from ideation to implementation", explains Andrei, who studies BSc International Business Finance and Economics at AMBS. This journey from uncertainty to clarity exemplifies how the programme equips participants with the critical thinking and strategic tools needed to navigate the challenging transition from concept to execution.

Looking Ahead: Demo Day 2025

The programme completion marks the beginning of the next phase for these emerging businesses. Participants will continue developing their ventures in preparation for the Venture Builder Demo Day on 8th October 2025.

The Demo Day represents a milestone in the entrepreneurial journey, offering participants a platform to demonstrate their progress, attract potential investment, and connect with key stakeholders in the 野狼社区 startup ecosystem.

The Venture Builder Programme is powered by MEC and designed for UoM students and graduate founders ready to transform their ideas into viable businesses. More information can be found on including registering interest to be part of the 25/26 academic year cohort.  

Register your interest for the Venture Builder Demo Day on the 8 October 2025.

The event is a joint collaboration between the University of 野狼社区, Athlete鈥檚 Journey Home and Drug Science and is supported by the British Association for Psychopharmacology. 

The event will feature world experts in the psychedelics field:  Prof David Nutt from Imperial College London and Prof Sara Tai from The University of 野狼社区. 

Three elite athletes: former professional rugby player, Rory Lamont; former professional ice hockey player, Daniel Carcillo; and former mixed martial artist, Ian McCall will talk about their own healing experiences. 

Organised by Jo Neill Professor of Psychopharmacology, from The University of 野狼社区, the event will explore scientific and real world evidence to show that psychedelic assisted therapy (PAP) may be able to alleviate some harmful effects of trauma in elite athletes. 

Clinical studies, fieldwork and personal accounts from across the world are now finding that PAP can induce neuroplasticity - the ability of the brain to reorganise and make new connections throughout life. 

And that may treat the cognitive decline, early dementia, severe headache and pain which are so common in brain injuries. 

Prof Neill said 鈥淭his is particularly relevant to elite athletes in sports such as rugby, football, ice hockey, horse riding, mixed martial arts and boxing. 

鈥淚n addition to injury, athletes experience emotional trauma from the high pressure environment of competitive sport, and gruelling training regimes, most evident when they leave that sport. 

鈥淏耻迟 psychedelic assisted therapy is known to reduce the emotional and physical impact of these forms of trauma and is even starting to be used by elite athletes for their mental and physical health in countries where it is legal. 

鈥淧AP is increasingly being recognised as a safe treatment though patients must always adhere to the law, and be well prepared in a very safe setting when taking the psychedelic medicines. They must also receive appropriate and extensive integrative therapy afterwards.鈥� 

The event takes place at the University鈥檚 Nancy Rothwell Building on Wednesday 2nd July at 2PM. 

Dr Grace Blest-Hopley and Nige Netzband, experts on Traumatic Brain Injury who work with psychedelics will also speak to the conference. 

Professor Neill added: 鈥淲hile most people find it extremely beneficial and indeed life-changing, PAP can be a very challenging and difficult experience for many. It is not be a medicine to be taken lightly. The treatment paradigm is 1-3 high doses in combination with therapy. Some people may not need to take this treatment again. This is very different from the current approach where people need to take a medicine every day which can have a significant side effect burden. 

鈥淚n spite of all the clinical and scientific evidence for their medicinal properties, particularly for disorders where nothing else works, they remain illegal Class A, Schedule 1 drugs in the UK. 

鈥淭he law is not evidence based and it enacts the harshest penalties for unlicensed manufacture, possession and supply. 

鈥淐linicians and scientists who want to conduct research require a controlled drugs licence from the Home Office, an expensive, bureaucratic and extremely time-consuming process. This must change.鈥� 

Tickets available here, free for BAP members.

CurrentBody Skin, one of the three innovative beauty technology brands owned by TBTG, has been at the forefront of home-use beauty technology globally since 2009 and is a pioneer in bringing LED light therapy to the home. CurrentBody Skin鈥檚 LED Light Therapy Face Mask uses 236 LEDs to emit the three most clinically recognised wavelengths for anti-ageing: red light, near-infrared and deep near-infrared. The efficacy and safety of the technology is underpinned by hundreds of clinical studies, alongside being endorsed by Doctors, dermatologists and aestheticians.

As awareness for our products grows, so does the desire for both education and science-backed beauty technology solutions. We are therefore investing heavily in clinical research for the future as the beauty technology market increasingly becomes a part of people鈥檚 skincare routines.

Home to one of the most active and comprehensive centres for dermatology research in the UK, The University of 野狼社区 was an obvious partner for our next clinical study. The 12-week clinical study will commence in September 2025 and will be led by Dr. Abigail Langton, PhD, who has an established record of internationally-recognised original research in the field of skin health and ageing.

The study will see a minimum of 20 healthy adult volunteers use the CurrentBody Skin LED Light Therapy Face Mask Series 2  for 10 minutes, five times per week for a 12-week period. In conjunction with the mask, a bespoke LED device for use on the forearm has been designed and manufactured to the same specification as the face mask. This bespoke device will be used on the volunteers鈥� forearms for the same duration as the face mask to support the clinical study. Participants will undergo non-invasive assessments of their face at the beginning, the halfway point and at the end of the study. In addition, small forearm skin biopsies will be taken at the start and at the end of the 12-week period.

The results from this new study will deepen our knowledge of our technology even further, leveraging pioneering techniques including biopsies of the skin to assess the extent of skin ageing and repair. It will evaluate the technology鈥檚 impact on photoaged skin, which is the result of long-term sun exposure over the years, often characterised by wrinkles, uneven skin tone, and dull appearance. It will focus on the impact on skin health and function on the face and forearm, including measures such as elasticity and hydration, as well as microscopic features of the forearm skin, such as epidermal thickness.

Laurence Newman, CEO of The Beauty Tech Group, commented: 鈥淎s the use of LED light therapy and other beauty technologies becomes increasingly commonplace in people鈥檚 lives, so has the increase in demand for education and proof of results. Unfortunately, imitation products, where the accuracies of wavelengths cannot be proven, have entered the beauty technology market and this is subsequently leading to confusion and misinformation. The need to validate and prove our technology is therefore more important than ever.

鈥淲e are addressing these challenges by ensuring each device that we produce can be traced back to its manufacturing to show the exact wavelengths in our CurrentBody Skin LED Face Mask Series 2. Partnering with one of the biggest faculties for skin in the country, and in our home city, will support our continuing journey in expanding the clinical aspect of the use of LED light therapy.

鈥淭his partnership not only demonstrates our commitment to leading the way in product design and development, but also shows our commitment to raise the standards across the industry. Most importantly, it aims to ensure that customers purchase high quality aesthetic products that are proven to work and are safe to use. I am proud of the work we are doing to innovate and progress the beauty technology industry, and look forward to publishing the results once the clinical trial is completed.鈥�

Dr. Abigail Langton added: "We鈥檙e thrilled to be collaborating with The Beauty Tech Group on this pioneering study into the effects of LED light therapy on skin ageing. By harnessing cutting-edge technology and combining it with our expertise in dermatological science, we have a unique opportunity to uncover how targeted light wavelengths influence the biology of photoaged skin. This research will generate powerful new insights into skin structure and function, helping to shape the future of science-backed, at-home skin treatments."

The White Paper takes recommendations from research carried out by University of 野狼社区 researchers based at the 野狼社区 Centre for Audiology and Deafness (ManCAD), funded by the Alzheimer鈥檚 Society and supported by the  National Institute for Health and Care Research (NIHR) 野狼社区 Biomedical Research Centre.

They found that unaddressed hearing loss is highly prevalent in care homes, impacting on residents鈥� quality of life.

The research identified several barriers relating to caregivers鈥� knowledge of hearing loss and opportunities for care homes to work with audiologists. Unclear responsibilities relating to hearing care and residents鈥� difficulties adapting to, or being comfortable wearing, hearing aids were also identified.

Titled 鈥淗earing Loss in Care Homes 鈥� A Call to Action鈥�, the paper brings together nearly a decade of practical experience from Engage鈥檚 work across over 35 care homes, alongside extensive research and insights from Nightingale Hammerson, where the Engage project has been running for over three years.

With at least 80% of residents in older people鈥檚 care homes living with hearing loss, the paper highlights the widespread impact of unaddressed hearing needs 鈥� from increased risks of dementia and falls, to social isolation, depression, and avoidable distress.

Professor Martin Green OBE, Chief Executive of Care England, said: 鈥淗earing loss has long been overlooked in care settings, despite its profound impact on wellbeing, safety, and social connection. This white paper, developed jointly with Engage and Nightingale Hammerson, is a timely and vital resource for the sector. It provides practical, evidence-based recommendations that care providers can implement to deliver more compassionate, inclusive and effective care.鈥�

The paper sets out a comprehensive set of evidence-informed recommendations including:

• Conducting environmental audits to reduce noise and improve lighting;
• Implementing clear protocols for hearing aid support and maintenance;
• Providing experiential hearing loss training for staff;
• Appointing Hearing Loss Champions to embed best practice;
• Ensuring access to personal amplifiers when hearing aids are not tolerated or unavailable;
• Improving access to audiology services and earwax removal;
• Supporting residents and families to explore and use assistive hearing technologies;
• Embedding person-centred communication, particularly for people living with dementia.

Dr Hannah Cross, Research Associate, 野狼社区 Centre for Audiology and Deafness (ManCAD) at The University of 野狼社区, said: 鈥淗earing care that is personalised, provided consistently and dementia appropriate can make huge changes to residents鈥� quality of life, wellbeing, independence and functioning.

"Meeting the hearing needs of care home residents with dementia is vital in maintaining their communication abilities, independence, and quality-of-life. 

"My PhD work outlined just how complex providing hearing care can be and how much needs to change. This White Paper will help to guide care homes in supporting their residents, and boost the priority of hearing loss within Social Care policy and regulation.鈥�

Padraic Garrett, Head of Engage and Andrew Goodwin, Service Manager for Engage, said: 鈥淲hen residents with hearing loss are not adequately supported, it leads to increased anxiety, depression, and social isolation, with higher risks to physical health issues including falls. From our many years of successfully collaborating with homes, our motivation for this Paper is to share what we have found works to address the suffering of residents with hearing loss.鈥�

Nuno Santos Lopes, Director of Research and Innovation at Nightingale Hammerson, added: 鈥淗earing loss is common to the vast majority of older people with care needs and the levels of knowledge of the care givers remains very low. From creating the right environment to get staff, managers and relatives knowledgeable about how to engage with someone with hearing loss, there is a lot of work to do and this document works as an easy to access guidance to help improving the hearing care standards.鈥�

The paper not only outlines an ethical and clinical imperative but also makes a compelling financial case: improved hearing care can reduce falls, mitigate cognitive decline, and enhance resident and staff wellbeing鈥攗ltimately supporting occupancy, reputation, and staff retention.

Care England urges all care providers to read the paper and implement its recommendations, using it as a foundation for improving practice and a platform to advocate for better audiology provision within local health systems.

Triangle CERSI is one of five Food and Drug Administration (FDA)-funded centres across the US, designed to promote innovation in regulatory science and accelerate access to complex emerging technologies. Located in Research Triangle Park, North Carolina, Triangle CERSI is a partnership between University of North Carolina at Chapel Hill and Duke University, in collaboration with North Carolina State University, North Carolina Central University, and the Burroughs Welcome Fund.

UK CEiRSI, jointly funded by InnovateUK and the Medical Research Council (MRC), operates under the leadership of the Christabel Pankhurst Institute in partnership with Unit M. This pioneering consortium has established a comprehensive national network that unites elite academic institutions鈥攊ncluding University of Oxford, University of Cambridge, University College London (UCL), University of Edinburgh, University of Strathclyde, Queens University of Belfast and Swansea University鈥攚ith key regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Health and Care Excellence (NICE) and Health Research Authority (HRA). With participation from 85 additional national and international stakeholders spanning academia, industry, and regulatory affairs, UK CEiRSI represents an unprecedented collaborative effort to integrate robust in-silico evidence into medical product development and regulatory decision-making pathways.

Professor Alejandro Frangi, Executive Director of UK CEiRSI, expressed his enthusiasm for the collaboration: 鈥淭his partnership represents a strategic milestone in global regulatory harmonisation. Triangle CERSI's pioneering work in virtual imaging trials and pharmaceutical regulatory science perfectly complements our comprehensive in silico capabilities across drugs and medical devices. By synchronising our regulatory approaches across continents, we're not simply sharing knowledge鈥攚e're building a unified scientific foundation that will accelerate innovation, reduce redundancy, and ultimately deliver safer, more effective medical technologies to patients worldwide. Together, we're transforming regulatory barriers into bridges.鈥�

Christin Daniels, Executive Director of Triangle CERSI, highlighted the importance of the partnership: "Partnering with UK CEiRSI creates a synergistic alliance to modernize regulatory science. Ensuring faster, safer solutions for patients worldwide requires a unified regulatory language. By combining Triangle CERSI鈥檚 expertise in pharmaceutical evaluation and safety, clinical trial optimization, in silico models and other New Approach Methodologies with UK CEiRSI鈥檚 impressive national network focused on comprehensive in silico technologies, we aim to close the gap between the pace of innovation and speed of adoption along the regulatory pathway on both sides of the Atlantic."

The MOU sets the stage for a series of joint initiatives, including workshops, training programs, and collaborative research projects. These efforts will not only advance regulatory science but also contribute to the development of a skilled workforce capable of navigating the complexities of modern healthcare. 

• "In-Silico"  is a term used to describe experiments or studies that are performed using computer simulations or software. 
• For more information visit: UK CEiRSI LinkedIn ; UK CEiRSI ;  InSilicoUK ; UK CEiRSI | InSilicoUK ; In Silico Trials, Real Impact! ; Triangle CERSI

In a new report from the Northern Health Science Alliance, partly based on research by University of 野狼社区 experts entitled 鈥淎geing in the North鈥�, researchers have catalogued an 鈥渁larming鈥� range of disadvantages faced by older people living in the North, in areas such as health, life expectancy, housing, nutrition, employment, and social isolation.

The authors stress that this inequality is mainly driven by economic and social factors, and is 鈥渢otally reversible鈥� - as long as policymakers are bold enough to act. For example, targeted investment has the potential to reduce or recover as much as 拢10.9 billion in lost productivity costs, 拢315 million in NHS costs from falls and hip fractures, and 拢588 million in NHS costs from treating conditions resulting from poor  housing.

鈥淎geing in the North鈥� is published by the Northern Health Science Alliance鈥檚 Ageing North network - including a multi-disciplinary team from Durham University, Lancaster University, The University of 野狼社区, Newcastle University, and the University of Sheffield - and Health Equity North. The team features expertise from a wide range of disciplines, from biology to sociology.

Researchers analysed existing data through a regional lens to examine the different ways in which ageing is experienced across England. They explored issues such as poverty and employment, health expectancies, long-term chronic conditions, frailty and falls, physical activity, nutrition, dementia and cognitive frailty, social support and unpaid care, social isolation and loneliness, housing and ethnicity.

The report - which you can read in full - states that:

鈼�     There are an estimated 904,200 economically inactive 50-64 year olds in the North: 170,100 in the North East, 428,600 in the North West, and 305,500 in Yorkshire and the Humber, contributing to a potential reduction in GDP of 拢10.9 billion per year

鈼�     People from the South are more likely to retire, while those in the North are more likely to leave the job market due to poor health

鈼�     Older people living in the North East and North West are 1.61 and 1.33 times, respectively, more likely to be frail, 1.16 and 1.06 times more likely to have a fall that requires hospital treatment, and 1.14 and 1.12 times more likely to have a hip fracture compared to older people living in the South East

鈼�     The cost to the NHS of falls and hip fractures in the North is NHS 拢55.7 million and 拢258.8 million per year respectively

鈼�     1.47 million northern homes are considered non-decent, with over a third housing over-60s residents. This is costing the NHS approximately 拢588 million in treatment per year

鈼�     In the ten years from 2012 to 2022, the North East and Yorkshire and the Humber have seen the rates of poverty among people aged 65 and over rise by 10%

鈼�     People aged 65 or over are 5% more likely to be deprived in the North (68%) than in the South (63%)

鈼�     Between 2020-21 and 2022-23, pensioner couples in the North East had an average income 14% lower than the national average and 25% lower than those in the South East

鈼�     Men aged 65 and over in the North East are predicted to have the highest number of unhealthy years of life on average, at 20.2 years. Yorkshire and Humber have 19.1, while the South East has 16.6

鈼�     The number of unhealthy years of life for older women in the North East is 23.7 years, compared to 19.4 years in the South East

鈼�     There is a two-year life expectancy gap between the North and the rest of England, with premature death rates 20% higher for those in the North

鈼�     Arthritis is more common amongst 55-64 year olds in the North (28%) than in the South (23%). Just 51% of people in the North East and Yorkshire and the Humber are seen for treatment within the national three-week target, compared to 79% in the South West

鈼�     Physical inactivity in the North East among 55-74 year olds is at 31% compared to 22% in the South East

鈼�     Northern adults over 65 are 27% more likely to experience food insecurity than those in the South

鈼�     Cognitive frailty (cognitive impairment plus physical frailty) in old age is more common in the North than in the South, with 11.8% living with cognitive frailty in the North East compared to 7% in the South East.

鈼�     Older adults in the North are 23.3% more likely to experience loneliness compared to the South, with northern women 1.55 times more likely to be lonely than men

鈼�     The three northern regions have the highest proportion of people aged 65 and over living in care homes, costing an estimated 拢4.83 billion in care home fees

鈼�     Minoritised ethnic groups consistently report poorer self-rated health than White British peers. Self-rated health is generally poorer in the North than in London and the South.

The report is being launched at an event in Westminster today (Monday, June 23, 2025) hosted by MP for Shipley, Anna Dixon, who wrote the Foreword.

Anna Dixon, Member of Parliament for Shipley, said: "Where you live shouldn鈥檛 affect your experience of ageing. This report brings into sharp focus the reality of how unequal ageing is across England. If we want to create a society that supports everyone to live and age better, we need to tackle the wider societal issues that result in some people in some communities dying earlier and living longer in poor health. This needs a life course approach, from childhood to adulthood, that enables people to remain active, stay healthy and contribute to society for as long as possible.鈥�

Leading academics behind the report are now calling on the Government to recognise the  challenges faced by people in later life and to prioritise tackling the root causes of unequal ageing. The report includes evidence-based policy recommendations, which could go a long way to reversing the widening inequality gap between North and South.

These recommendations include:

鈼�     Adopting a cross-government approach to prevent unequal ageing, looking at themes such as education, housing, employment and health

鈼�     Strengthening place-based collaboration between local government, combined authorities, housing developers, the NHS, and older adult

鈼�     Developing and delivering a national housing strategy for older people that prioritises ageing in place and invests in age-friendly, accessible homes

鈼�     Significantly increasing investment in adult social care in the North of England

鈼�     Developing an NHS-led, UK-wide strategy to address physical inactivity as a key driver of later-life health inequalities

鈼�     Producing a national strategy to recognise and address cognitive frailty as a preventable condition distinct from dementia

鈼�     Identifying the regions most at risk of diseases such as arthritis, cardiovascular disease and diabetes, and adopting a proactive preventative strategy which expands community-based services and strengthens early intervention

鈼�     Expanding workplace health programmes and improving healthcare access disparities

鈼�     Developing tailored place-based strategies to reduce loneliness among older people, focusing on groups at highest risk, such as women, minoritised ethnic groups, people who are living alone, or with poor health

鈼�     Addressing food insecurity in later life through stronger national tracking and targeted local action

鈼�     Improving the collection and use of ethnicity and regional data across health and care systems to better understand and inform culturally-appropriate and regionally-sensitive responses

鈼�     Strengthening support for unpaid carers of older people by increasing carer鈥檚 allowance and carer-related benefits.

Emeritus Professor Alan Walker, from the University of Sheffield鈥檚 Healthy Lifespan Institute, said: 鈥淭his report paints an alarming picture of how inequality has eaten away at the quality of life of so many older northerners. In almost every aspect we investigated, there is a yawning gap between the North and the South - from their income and health to their housing, social care and sense of isolation.

鈥淭his gap is hardly new, but the most frustrating thing about it is that it is totally reversible - assuming that policymakers are willing to take decisive steps to address these issues, and provide a better life for our family members, friends, and neighbours as they age.鈥�

Professor Chris Todd, from The University of 野狼社区, said: 鈥淭he country has faced several crises in recent years, from austerity to the COVID-19 pandemic. Older people in the North have carried more than their fair share of that burden.

鈥淭he reality is now stark. Older people in the North are more likely to be poorer, and to live shorter, less-healthy, more isolated lives in sub-optimal accommodation.

鈥淭he gap is growing every day. We need proactive policies - targeted at areas of greatest need - to reverse this trend and enable the North to age with hope, rather than inequality.鈥�

Professor Carol Holland, the Director of Lancaster University鈥檚 Centre for Ageing Research, said: 鈥淯nequal ageing is not inevitable. The gulf between North and South has been created and exacerbated by long-term national policies. And it can be reversed in the same way.

鈥淭he evidence presented in this report does not merely highlight all the ways that people experience ageing differently in the North and South. It offers a clear call to action, to make it a national priority to address this inequality - and vastly improve the lives of millions. We know a lot about prevention and risk reduction of later life difficulties such as frailty or cognitive impairment: it is not enough to claim that nothing can be done. It is time to be bold, and do better.鈥�

Professor Barbara Hanratty, Professor of Primary Care & Public Health at Newcastle University, said: 鈥淔or many, it is harder to grow old in the North than in the South. There are some deep-seated and long-term reasons for that. But we must also acknowledge that the situation is being influenced by decisions that are being made today.

鈥淎verage earnings in the North amongst those aged 65 and over are the lowest in England, and poverty has increased over the last ten years. People in the North are more likely than their neighbours to leave the workforce due to ill-health. We need real policy changes to tackle the root causes of this inequality, with more targeted initiatives to address the many disadvantages facing older people in the North.鈥�

Professor Charlotte Clarke, Associate Pro-Vice-Chancellor (Health) at Durham University, said: 鈥淭he factors that contribute to the struggles faced by older people make their presence felt far earlier - in childhoods and adulthoods where poverty, poor housing, ill-health and other disadvantages are all too common.

鈥淚t is absolutely essential that policymakers act to help our older citizens. But they must also recognise that these issues are the result of lifelong experiences and inequalities. To achieve real tangible change, we need policies that improve lives as a whole - and tackle these issues long before they escalate.鈥�

Hannah Davies, Chief Executive of the Northern Health Science Alliance and Executive Director of Health Equity North, said: 鈥淭he North is a beautiful place to grow old. We have some of the most breathtaking scenery in the country, as well as welcoming and tight-knit communities. And yet, the day-to-day reality of ageing for many northerners is far harder than it should be.

鈥淲e have often talked about the inequalities that exist in the North, and this report is a reminder of why the gap between North and South continues to widen. There is clear evidence of this on so many fronts - from poverty levels to housing quality, frailty, nutrition, and social support. The divide is particularly pronounced amongst older adults from diverse ethnic backgrounds, which highlights the need for culturally-sensitive solutions which recognise community needs.

鈥淚t is undeniable that we need to offer urgent help to older people who are dealing with these issues. It is also our responsibility to make sure that future generations do not have to go through the same challenges - with targeted, considered policies that address the lifelong issues that are so familiar to northern citizens.鈥�

Read the full 鈥淎geing in the North鈥� report here:

The fellowship is the College鈥檚 highest award for non-GPs and previous fellows include Sir Chris Whitty, Sir Michael Marmot, three former presidents of the Royal College of Psychiatrists and the TV chef Jamie Oliver. 

 Nav who is also Director of the UK鈥檚 National Confidential Inquiry into Suicide and Safety in Mental Health and Honorary Consultant Psychiatrist at Mersey Care NHS Foundation Trust said: 

鈥淚鈥檓 delighted to be awarded the Fellowship.  At medical school I only really considered two career paths 鈥� psychiatry and general practice 鈥� and it could have gone either way!  So to be recognised by the Royal College of General Practitioners feels really special.  I鈥檓 very grateful to them and the people who nominated me.  

鈥淚 would like to thank all my colleagues, patients, carers and others who have helped with our research.  I also want to thank my family, especially my big brother Sanj, a fantastic GP who retired recently and without whom I would never have become a doctor.鈥� 

The fellowship means that Nav now has the letters FRCGP (Hon)鈥� after his name. 

The citation for the Fellowship from the Royal College of General Practitioners highlighted Nav鈥檚 world leading suicide prevention research as well as his work for NICE, the UK Department of Health, and health services.  

The citation went on to say: 鈥淎ll of his research has had a clinical real-world focus and much of it is relevant to primary care. His work has identified suicide prevention as a core safety responsibility of health and social care services.  He has been a long-standing friend of general practice and his work has most certainly led to enhanced GP care for people presenting with mental health concerns鈥�

The University tops both the global league table of publications and citations at 177 and 12,313 respectively. 

The output was predominantly driven by Professor David Denning from The 野狼社区 Fungal Infection Group (MFIG) at the The University of 野狼社区, the most published and most cited author at 89 papers and 9850 citations.

 He was followed by Thomas J. Walsh from the United States at 72 papers and 6,036 citations, and Dimitrios P. Kontoyiannis also from the United States ranking third at 66 papers, 6404 citations. 

Invasive aspergillosis a potentially lethal infection, usually of the lungs, is thought to affect over 2 million people each year. 

According Professor David Denning, one of the world鈥檚 leading experts on fungal disease, global outcomes for patients with invasive aspergillosis have improved markedly in recent years.

The success, he argues, is partly down to the huge amount of research activity devoted to the topic in 野狼社区 and at centres across the globe. Professor Mike Bromley, Head of MFIG said: 鈥淲e have made significant inroads to improving outcomes for patients suffering from the devastating diseases caused by Aspergillus, but much more needs to be done.鈥�

MFIG have recently worked with the WHO to highlight the need for additional efforts in antifungal drug and

However the disease still has a high mortality rate, particularly in immunocompromised people and those in intensive care, who can experience severe complications including bleeding and spread from the lungs to the brain.

Professor Denning said: 鈥楽ince I first encountered invasive aspergillosis as a trainee doctor in the mid 1980鈥檚 when it was poorly understood, my clinical and research focus has been focussed on improving what was then a dismal outcome for these patients.

鈥淕reat strides in both diagnosis and treatment have been made since 2002, with what was almost a universally fatal disease before the millennium to around 30% in the best performing hospitals.

鈥淭he improvement is down to major studies, agreed diagnostic criteria and application of accepted guidelines for caring for patients.

鈥淗owever there continues to be a desperate need to build on these gains in every hospital globally so we can continue to improve the outlook for these often complex and vulnerable patients.

鈥淲orking with major pharmaceutical companies on the clinical development of key antifungal drugs voriconazole, caspofungin, and micafungin and the preclinical development of anidulafungin, posaconazole and isavuconazole has been an extraordinary journey.鈥�

The figure of 177 papers dwarfs the others in the top 4:  Radboud University Nijmegen in the Netherlands published 92 papers, MD Anderson Cancer Center in Houston 90 papers, and the University of Texas 81 papers.

This research is supported by three major units at The University of 野狼社区:  the 野狼社区 Fungal Infection Group (MFIG), the National Aspergillosis Centre and the 野狼社区 Mycology Reference Centre.

MFIG has recently been awarded some significant research grants: Prof Bromley, Dr Bertuzzi and Dr Bottery of MFIG have recently received 3 awards, totalling over 拢2 million from the Wellcome Trust to explore new ways of combatting fungal infection.

About our international research
The University of 野狼社区 is globally renowned for its pioneering research, outstanding teaching and learning, and commitment to social responsibility. We are a truly international university 鈥� ranking in the top 50 in a range of global rankings 鈥� with a diverse community of more than 44,000 students, 12,000 staff and 550,000 alumni from 190 countries.  Sign up for our e-news to hear first-hand about our international partnerships and activities across the globe. 

Professor Turajlic has been an independent research group leader at the Francis Crick Institute since 2019 and is a consultant medical oncologist at The Royal Marsden NHS Foundation Trust. She is expected to take up her new position in September 2025.

Welcoming the appointment, Michelle Mitchell, chief executive of Cancer Research UK, said: 鈥淧rofessor Turajlic is an outstanding clinician scientist with a remarkable track record in cancer research.

鈥淗er leadership will enable the 野狼社区 Institute to continue to grow as a place where world-class clinicians and scientists work alongside one another to better understand the fundamentals of cancer and apply that knowledge to transform cancer treatment in the future.鈥� 

Professor Turajlic鈥檚 work spans basic, translational and cancer research, and she has led numerous pioneering studies that have significantly advanced our understanding of cancer biology and treatment.

Her work on the TRACERx Melanoma and TRACERx Renal projects has provided groundbreaking insights into the genomic signatures of cancer progression and the response and resistance to targeted therapies. Such studies are pivotal in understanding how we bring new therapies from the lab to the clinic and how we tailor personalised treatment plans for cancer patients, improving outcomes and quality of life.

Since 2024, Professor Turajlic has led the UK consortium MANIFEST, which aims to understand how patients respond to immunotherapy, making treatments both safer and more effective 鈥� a major unmet scientific and clinical need.

Research at the Cancer Research UK 野狼社区 Institute spans the spectrum of cancer research, including tumour-host interactions, microenvironment, biophysical regulation of tumour function, genetic and non-genetic drivers of tumour evolution, and response to therapy. 

Professor Turajlic said: 鈥淚鈥檓 honoured to be taking on the role of Director of the Cancer Research UK 野狼社区 Institute and look forward to working alongside such a talented community of scientists and clinicians.

鈥淭ogether with its partners, the institute is poised to deliver transformational cancer research in the coming years. I am excited to lead the institute in its mission to deliver for people with cancer.鈥�

Professor Turajlic鈥檚 contributions to the field have been recognised with numerous awards, including the ESMO Society Award for Translational Research for her work in cancer science and translational medicine. She received the UK COVID Cancer Pandemic Prize for her work on cancer and COVID-19, which informed health policy for patients. In 2018, Professor Turajlic was named as one of the 鈥�50 Movers and Shakers in BioBusiness鈥� by life sciences network BioBeat. [HP4] 

It's an exciting moment to join the institute less than 12 months on from the official opening of the state-of-the-art new Paterson Building.  Located in Withington, South 野狼社区, the site hosts 700 researchers, clinicians, and operations staff, and directly connects a research facility with The Christie, one of Europe鈥檚 largest cancer hospitals. It houses the facilities and expertise to be one of the world鈥檚 leading comprehensive cancer centres, helping scientists get new treatments from bench to bedside.

Professor Turajlic will take over from Professor Caroline Dive, who has been interim director for four years, providing exceptional scientific leadership during the pandemic and the move to the Paterson Building. Professor Dive continues as director of the Cancer Research UK National Biomarker Centre and co-lead of the Cancer Research UK Lung Cancer Centre of Excellence, supported by ScottishPower. 

President and Vice-Chancellor of The University of 野狼社区, Duncan Ivison, said: 鈥淚t is fitting that the Cancer Research UK 野狼社区 Institute, a world-leading cancer research centre focusing on a wide range of research areas from basic science to clinical trials, is to be led by a world-leading clinician scientist , Professor Samra Turajlic.

鈥淧rofessor Turajlic鈥檚 contributions to the study of cancer have been recognised around the world and I am delighted to welcome her to the 野狼社区 family.鈥�

Chief Executive of The Christie NHS Foundation Trust, Roger Spencer, said: 鈥淲e are very excited to welcome Samra Turajlic at this significant moment in our history as we embark on a new era of cancer research in the Paterson Building.

鈥淚 know Samra鈥檚 outstanding leadership and expertise will benefit the unique collaboration of 野狼社区鈥檚 鈥楾eam Science鈥� and keep our city at the forefront of new innovations in cancer treatment, bringing therapies from the bench to the bedside to benefit our patients now and in the future.鈥�